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Abstract
Janus kinase 1 drives endoplasmic reticulum stress-induced transcriptional
reprogramming in astrocytes.
Savannah G. Sims
Neurological and neurodegenerative diseases are heterogenous and devastating
diseases with limited therapeutic options and no cures. The broad, long-term goal of this
project was to elucidate therapeutic targets for neurodegenerative conditions that
attenuate damaging inflammation while leaving the beneficial immune response intact
and avoiding broad immunosuppression. Inflammation and the accumulation of misfolded
proteins are associated with a wide variety of neurological diseases. Here, we have
examined how the accumulation of misfolded proteins shapes inflammatory signaling in
the glial cell population astrocytes. Astrocytes are the most populous cell in the central
nervous system (CNS) and provide physical and trophic support to the CNS. Proper
astrocyte function is paramount for a healthy brain. Recent evidence indicates
endoplasmic reticulum (ER) stress and inflammation are linked. ER stress occurs when
the protein folding capacity of the cell is overwhelmed, resulting in the initiation of the
unfolded protein response (UPR) to regain homeostasis. However, unresolved UPR
activation leads to cell death and aberrant inflammation. Further, astrocytes are relatively
resistant to ER stress-induced cell death. We have found that UPR activation in
astrocytes activates JAK1-dependent inflammatory gene expression. Canonical JAK1
signaling is initiated by ligand binding of a cytokine receptor that results in Signal
Transducers and Activators of Transcription (STAT)-dependent inflammatory gene
expression. Using RNA sequencing of primary murine astrocytes, we have demonstrated
that JAK1 regulates approximately 10% of ER stress-induced gene expression. However,

we found JAK1 initiates different gene expression based on the activating stimulus. In
response to ER stress, JAK1 regulates a distinct subset of gene expression that we
hypothesize does not rely on JAK1-dependent phosphorylation of STATs. Instead, we
have described a noncanonical role for JAK1 in response to ER stress that utilizes the
transcription factor activating transcription factor (ATF) 4. ATF4 is expressed in response
to ER stress and other types of cell stress. We demonstrate here that JAK1 and ATF4
coimmunoprecipitate, suggesting a physical interaction between these two proteins.
Further, we showed via ChIP-seq that JAK1 is required for ATF4 to bind transcription start
sites in promoter regions. Here, we have demonstrated a mechanism by which JAK1
regulates ER stress-induced gene expression in astrocytes in a noncanonical
mechanism. Future directions of this project will focus on understanding the physiological
consequences of this pathway in vivo in models of neuroinflammation.
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Introduction and Background
Introduction
Neurodegenerative diseases are characterized by the progressive loss of neuronal
function, cognitive decline, and eventual death. As reported in 2017, the estimated
financial burden of neurological diseases is approximately $800 billion a year [1, 2]. The
largest risk factor of suffering from a neurological disease is age. Twenty five percent of
the United States population will reach the age of 65 by 2050, meaning a large portion of
the population will be at great risk for developing a neurodegenerative disease [3]. No
curative treatments are available, and the prevalence of these diseases is continuing to
rise with a globally aging population. While neurological and neurodegenerative diseases
are widely heterogeneous, we have focused our interests in evaluating molecular
signaling pathways in astrocytes, cells that comprise over half of the cellular composition
of the Central Nervous System (CNS), that serve as common links between multiple
neurodegenerative diseases to help identify mechanisms that could expand the
knowledge base to develop pragmatic post-diagnosis treatment.
Astrocytes are glial cells that support proper neurological function in the Central
Nervous System (CNS), in part, by providing structural support for neuronal synapses
and blood vessels, participating in electrical and chemical transmission, and providing
trophic support via soluble factors. Dysregulation of astrocyte function contributes to
neurological decline in CNS diseases. Astrocytes comprise a large portion of the CNS [4,
5]. Historically, astrocytes were viewed as a homogenous population that primarily played
a role in structural support to the CNS, however, technical advances and meticulous
1

experimentation have shown that astrocytes are a heterogeneous and dynamic
population of CNS-resident cells, playing important roles in both homeostasis and
disease. For example, astrocytes support synapse formation and function through both
physical interactions and secreted molecules [6]. Astrocytes play a role in synaptic
pruning during development, a process which is essential for proper neural development
[7]. Astrocytes also support synaptic function by regulating homeostasis of ions (Ca2+, Cl, K+), water transport, and neurotransmitter reuptake and recycling [8, 9].

Figure 1.1 Astrocytes produce a variety of JAK-STAT dependent cytokines.
In addition to their supportive role, astrocytes respond to insult and injury, can
promote neurotoxicity, and direct CNS inflammation by promoting microglial activation
and leukocyte trafficking. Inflammation, particularly proinflammatory cytokines such as
interleukin (IL) - 6, IL-1, tumor necrosis factor (TNF) -α, and the complement system, play
an important role in neurological diseases and are associated with worsened neurological
outcomes [10-14]. Astrocytes are key directors of inflammation within the CNS. It is well
established that astrocytes undergo transcriptional and phenotypical changes in
response to injury, called astrogliosis [9]. During astrogliosis, astrocytes are more
2

proliferative, glial fibrillary acidic protein (GFAP) expression increases, signaling
molecules and cytokines are upregulated, the extracellular matrix remodels, and changes
in ability of astrocytes to properly regulate synapses and the blood brain barrier (BBB)
occur. Reactive astrocytes have opposing roles on disease states. For example, reactive
astrocytes worsen spinal cord injury, but during ischemia, reactive astrocytes promote
overall neural recovery [15-22].
Reactive astrocytes are known to contribute to the pathology of neurological
disease, in part, by producing soluble inflammatory mediators such as IL-1β, TNF-α,
CXCL1, CXCL10, CCL2, CCL7 CCL20, IL-6, IL-10, and IL-15 to modulate the
inflammatory milieu of the CNS. Many of these cytokines and chemokines rely on Janus
Kinase (JAK) – Signal Transducer and Activators of Transcription (STAT) signaling
(Figure 1.1). The JAK-STAT family is an important signaling pathway that is comprised
of four JAK proteins (Tyk1, JAK1, JAK2, JAK3) and seven STATs (STAT1, STAT3,
STAT4, STAT5a, STAT5b, STAT6) proteins. The JAK-STAT family is responsible for
coordinating immunological responses to a multitude (reportedly over 70) of cytokines,
chemokines, and growth factors. Because each JAK and STAT protein can homo- or
heterodimerize to drive transcription, the various combinations of these JAKs and STATs
provides great complexity in this signaling pathway. Historically, the JAK-STAT signal
transduction cascade was discovered by examining the antiviral responses of interferons
(IFN) and gene expression. IFNs were discovered as a secreted product that interfered
with viral replication [23]. IFN receptors do not have intrinsic kinase activity, so these
receptors rely on JAKs to mediate phosphorylation and activation of STATs.

3

To mediate cytokine induced signaling, JAK proteins are constitutively associated
with the cytoplasmic portions of cytokine receptors that span the plasma membrane.
Cytokine receptors are activated upon ligand (cytokine) binding. Cytokine receptors
bound to their cytokines undergo a conformational change that brings JAK proteins into
proximity. JAKs auto phosphorylate and this phosphorylation occurs on an activation loop
to increase the intrinsic kinase activity of JAKs [24]. JAKs then phosphorylate the cytokine
receptor on tyrosine residues. These tyrosine residues are then recognized by STAT

Figure 1.2 JAK1 is well-established to signal through a variety of cytokine
receptors.
proteins because STATs contain SH2 domains. STATs are recruited to the cytokine
receptor via these SH2 domains where JAKs can phosphorylate STATs [25, 26].
Phosphorylated STATs can hetero- or homodimerize. Upon dimerization, a nuclear
localization sequence is exposed. STAT dimers translocate to the nucleus and bind
promoter regions to initiate cytokine-induced gene expression [27].

4

The JAK-STAT signaling cascade has been widely studied and associated with
many diseases, including neurodegenerative diseases [28]. There are a number of
pharmaceutical inhibitors in use and in clinical trials designed to inhibit JAKs and STATs
primarily applied to treatment of cancer and immune disorders [29]. These JAK inhibitors
are also undergoing clinical trials for many autoimmune diseases such as rheumatoid
arthritis and irritable bowel disease, as well as neoplastic diseases (58). Five JAK
inhibitors have received FDA approval (28). Baricitinib (Olumiant), tofacitinib (Xeljanz),
and upadacitinib (Rinvoq) are currently approved to treat rheumatoid arthritis. Ruxolitinib
(Jakafi/Jakavi) is approved by the FDA to treat myelofibrosis and polycythemia vera.
Fedratinib (Inrebic) is also FDA approved to treat myelofibrosis [30, 31]. Inhibitors of
STAT3 and STAT5 also are utilized as research tools and are undergoing investigation
as potential cancer treatment (59,60). In addition to clinical applications, the availability
of these inhibitors is useful for basic research to determine the significance of JAK-STAT
signaling in the context of neurological disease. However, it is important to note that all
JAK inhibitors will have broad impacts in all cells that express the targeted JAK proteins.
For example, JAK inhibitors will likely make patients taking these medications more
susceptible to certain viral, bacterial, or fungal infections. Therefore, patients will require
monitoring and counseling concerning these treatments [32, 33].
Mouse knockout experiments have helped us gain critical knowledge on the role
of JAKs and STATs in vivo. JAK1 knockouts in mice are perinatal lethal and newborn
pups exhibit loss of hematopoietic function [34, 35]. JAK2 knockouts are embryonic lethal
[36]. JAK3 knockout mice exhibit severe combined immunodeficiency with a loss of all
mature B and T cells [37, 38]. Tyk2 knockouts are viable but experience major anti-viral
5

immune deficits and lack responses to type I interferons, IL-12, and IL-23 family cytokines
[39]. Much of this animal work has been strengthened in human studies. Loss of function
mutations in JAK1 result in primary immunodeficiency accompanied by frequent
infections. Some cancers are associated with JAK1 loss of function. Further, mutations in
JAK1 that cause a gain of function result in hyper eosinophilic syndrome [40] and other
immune problems, including reports in cancers [41-43], complex autoinflammatory
syndrome [44], and, atopic dermatitis [40], psoriasis [45]. Loss of function mutations in
JAK2 have not been characterized, which is consistent with JAK2 knockouts being
embryonic lethal in mice. However, JAK2 gain of function mutations are associated with
many cancers including myeloproliferative neoplasms, leukemia, and lymphoma.
Consistent with JAK3 knockouts in mice, JAK3 loss of function mutations in humans also
causes SCID. Gain of function mutations are associated with development of leukemia.
Tyk2 loss of function mutations are associated with primary immunodeficiency, however,
Tyk2 loss of function is associated with protection against autoimmunity. Gain of function
mutations in Tyk2 are not established.
JAK1 and JAK2 are the primary JAK signaling proteins in the CNS; expression of
Tyk2 and JAK3 is primarily restricted to cells of hematopoietic lineage. JAK-STAT
signaling is required for astrocyte development. In one of the first studies to demonstrate
this, it was shown that ciliary neurotrophic factor (CNTF) receptor ligation activates JAK1dependent phosphorylation of STAT1 and STAT3 to commit neuronal precursor cells to
the astrocyte lineage [46, 47]. CNTF is a member of the IL-6 family signaling pathway,
and other similar cytokines, IL-6 and LIF, can trigger similar effects [48]. Further, mice
lacking the LIF receptor have reduced numbers of astrocytes [49]. Taken together, these
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studies suggest that JAK-STAT signaling is relevant in astrocytes and early expression is
vital for development.
Because JAK-STAT signaling is necessary for astrocyte development, this
provides a clear physiological role for these proteins in the CNS. However, aberrant JAKSTAT signaling is reported in neoplastic disease. Alterations in JAK-STAT signaling is
observed in grade III/IV gliomas and medulloblastoma. In primary high-grade gliomas,
STAT3 is constitutively activated in 60% of these malignant tumors and is driven by
EGFR-mediated phosphorylation of JAK2. Further, STAT3 expression positively
correlates with tumor grade, suggesting that STAT3 is oncogenic in the brain. These data
suggest that there is potential to target JAK-STAT signaling components in gliomas to
sensitize these tumors to effective treatment with anti-EGFR therapies. Constitutive
activation of STAT3 is thought to drive proliferation and survival of glioblastoma and
glioma cells. [50-52].
In addition to brain cancers, JAK-STAT signaling is activated in traumatic and
ischemic CNS injury. Importantly, STAT3 is required for GFAP expression. GFAP is a
primary marker of astrogliosis, an astrocytic phenotype associated with disease and injury
and required for glial scar formation (astrogliosis) [17, 53, 54]. Astrocytes in models of AD,
HD, and MS also express higher levels of phosphorylated STAT3 compared to controls
[55]. Additionally, JAK inhibition ameliorates disease progression in rodent models of PD
and MS [56, 57]. In the APP/PS1 AD mouse model, deletion of STAT3 in astrocytes was
associated with decreased expression of amyloid-β in the brain and reduced disease
burden. Further, a STAT3 inhibitor reduced cognitive problems in the AD-prone mice.
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This suggests that STAT3-driven astrogliosis may drive disease progression in AD. [58].
Despite the clear involvement of JAK-STAT signaling in a variety of neurological
diseases, the mechanisms, and cell-specific contributions of JAK proteins has not been
greatly explored. JAK1 is known to associate with the common γ receptor of type I
interferon receptors, the IL-2 family receptors, IL-4 family receptors, and the gp130
receptors of the IL-6 cytokine family, the cardiotrophin receptor, and the IL-10 family
receptors (Figure 1.2). The cell-specific contributions of JAK1-driven neuroinflammation
are unknown. Therefore, we are interested in understanding JAK-dependent mechanisms
in astrocytes in response to cellular stress that is associated with a variety of neurological
diseases.
We have identified JAK1 as a specific regulator of endoplasmic reticulum stressinduced inflammation in astrocytes. JAK1 in neurons is associated with proprioception.
Interestingly, the JAK1 inhibitor oclacitinib is used in veterinary applications to treat dogs
with pruritus associated with allergic dermatitis [59]. Understanding the cell-specific
contributions of JAK1 signaling has been difficult due to limitations of in vivo models.
Neurodegenerative diseases are accompanied by inflammation and cell stress,
including compromised protein structure and function. Well-established links between
misfolded proteins and several neurodegenerative diseases exist including but are not
limited to Alzheimer’s disease (amyloid-β, tau), Parkinson’s disease (α-synuclein),
Huntington’s disease (Huntingtin with expanded glutamine repeats), spongiform
encephalopathies (prions). However, therapeutically targeting misfolded proteins has
been unsuccessful in clinical trials [60]. When there is an excessive accumulation of
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misfolded or unfolded proteins in the ER lumen, endoplasmic reticulum stress occurs. We
have identified endoplasmic reticulum stress as a stimulus that promotes inflammatory
astrocytes.
Astrocytes have been demonstrated to express many inflammatory signaling
molecules, and activation contributes to the inflammatory environment of the CNS [61] .
Further, ER stress has been explicitly linked to initiating inflammation. For example, ER
stress augments inflammatory responses stimulated by the bacterial cell wall component
lipopolysaccharide (LPS) and can directly drive activation of the acute phase response
[62, 63]. Taken together, accumulating evidence suggests that chronic ER stress and
subsequent signaling may drive inflammation in astrocytes and contributes to
neurological disease.

Endoplasmic Reticulum Stress and the Unfolded Protein Response
Secreted and membrane bound proteins are translated and processed in the
endoplasmic reticulum (ER). Within the ER, proteins mature by folding into the proper
tertiary and quaternary structure and acquire necessary post-translational modifications.
The ER is also critical for membrane lipid production and for the regulation of intracellular
Ca2+ [64]. Often, proteins within the ER fail to fold into the correct form. Fortunately, the
cell has intrinsic quality control mechanisms that eliminate misfolded proteins, such as
chaperone-mediated folding [65] and ER associated degradation (ERAD) [66, 67].
However, when these control mechanisms are overwhelmed, misfolded proteins
accumulate in the ER lumen. The aberrant accumulation of misfolded proteins and
concomitant induction of ER stress has been observed in many diseases and cell types
[68, 69]. ER stress occurs when a cell can no longer keep up with the demand to fold
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proteins due to the number of misfolded proteins in the ER lumen. ER stress initiates a
highly conserved adaptive mechanism called the unfolded protein response (UPR). The
intracellular signaling stimulated by ER stress is aimed at restoring homeostasis;
however, if the stress is not alleviated, prolonged ER stress can drive cell death and
inflammation which may contribute to pathology [69].
ER stress can occur transiently in physiological conditions when there is an

Figure 1.3 The canonical Unfolded Protein Response (UPR) is activated by 3
trans-ER membrane sensors: IRE1, PERK, and ATF6. Figure was created in
Biorender.

increased demand for protein secretion, or in pathogenic states where ER stress occurs
due to genetic mutations, oxidative stress, ischemia, or other maladaptive cellular states.
Although UPR activation is necessary to maintain homeostasis and clearly plays a role in
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homeostatic processes, tight regulation of the UPR is paramount for maintaining cellular
health. Persistent activation of the UPR is reported in multiple diseases, including
diabetes, cancer, and neurodegeneration [70-72].
There are three known proteins which sense the accumulation of misfolded
proteins and transmit distinct signals to the cytosol and nucleus to modify transcriptional
and translational programs to cope with ER stress, summarized in Figure 1.3. These
trans-ER membrane proteins are inositol requiring enzyme 1 (IRE1), protein kinase Rlike ER kinase (PERK) and activating transcription factor (ATF) 6. These enzymes are
maintained in their inactive state through interaction with the ER-resident protein
chaperone glucose regulated protein (GRP) 78 (also known as binding immunoglobulin
protein (BiP)) [73]. GRP78 binds broadly to hydrophobic residues that are exposed by
misfolded proteins [74]. Excess misfolded proteins recruit GRP78 away from the luminal
domains of PERK, IRE1, and ATF6 allowing activation [75, 76]. PERK and IRE1 can also
directly interact with misfolded proteins which contributes to its activation via a ligandreceptor type interaction [77-81]. Figure 1.3 provides an overview of the UPR signal
transducing molecules.
IRE1 is the most evolutionarily conserved UPR initiator and contains both kinase
and endoribonuclease domains. Following release of GRP78, IRE1 oligomerizes in the
ER membrane facilitating trans-autophosphorylation of IRE1 which increases RNase
activity [82-84]. IRE1 then splices the mRNA of x-box-binding protein (XBP1) to remove
a small stop codon-containing intron which allows translation of the functional
transcription factor [85]. Additionally, the RNase activity of IRE1 mediates regulated IRE111

dependent decay (RIDD), in which a subset of ER-targeted mRNAs are degraded [86,
87]. Collectively, IRE1 drives XBP-1-dependent gene expression that includes ER
chaperones and, through RNA degradation, reduces nascent polypeptide entry into the
ER to reduce the folding demand [87, 88].
PERK is a trans-ER membrane serine/threonine kinase which is activated by
misfolded proteins in the ER lumen. Following release of GRP78, PERK dimerizes and
trans- and auto-phosphorylates to increase its kinase activity [73, 89]. PERK
phosphorylates the eukaryotic initiation factor (eIF) 2α which leads to binding and
inhibition of the guanine nucleotide exchange factor (GEF) eIF2B. This prevents formation
of the complex needed to load the 43S ribosome with methionine, thus preventing
translation initiation [90, 91]. Under these conditions, some proteins are selectively
translated. For example, activating transcription factor (ATF) 4 is translated when eIF2α
is phosphorylated. ATF4 translation can lead to expression of CHOP (encoded by the
gene ddit3). In many cases, CHOP acts as a proapoptotic factor. Overall, PERK activation
in response to ER stress reduces the protein load on the ER, and if mechanisms fail to
restore homeostasis, initiate cell death.
ATF6 is a transmembrane glycoprotein that is a member of the basic leucinezipper proteins (bZIP) transcription factor family. Upon the accumulation of misfolded
proteins and disassociation of GRP78, ATF6 localizes to the golgi apparatus where is
cleaved by site-1 and site-2 proteases [92], revealing a nuclear localization sequence.
Subsequently, ATF6 translocates to the nucleus and binds promoter sequences to initiate
gene expression of ER protein chaperones and UPR regulators to increase folding
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capacity of the ER [93]. Overall, IRE1, PERK, and ATF6 are activated in response to the
accumulation of misfolded proteins within the ER lumen to promote efficient protein
folding through the upregulation of protein chaperones and by reducing the folding burden
on the ER by eliminating influx of mRNA and polypeptides. If these mechanisms are
insufficient, persistent UPR activation will promote apoptosis to eliminate the irreparably
damaged cell.
ER stress can occur transiently in physiological conditions when there is an
increased demand for protein secretion, or in pathogenic states, where ER stress occurs
due to genetic mutations, oxidative stress, ischemia, or other maladaptive cellular states.
ER stress has been best characterized in cells harboring high secretory capacities such
as pancreatic β cells and antibody-producing B cells. For example, cell specific knockout
of PERK in β-cells results in hyperglycemia and pancreatic atrophy, suggesting that
PERK is required for correct β-cell function. This indicates that pancreatic β-cells
experience physiological levels of ER stress to efficiently fold insulin precursors to meet
the demand to maintain proper blood glucose concentrations. IRE1 also down regulates
insulin at the mRNA expression level in vitro. Thapsigargin (an inhibitor of the
sarco/endoplasmic reticulum Ca2+ ATPase that induces ER stress by depleting the ER
stores of calcium) and glucose induces the degradation of insulin mRNA. Expressing a
kinase dead mutant of IRE1 in these cells abrogated this effect. This demonstrates that
IRE1 can degrade insulin mRNA under ER stress conditions when the demand to produce
insulin is high [94]. However, dysregulated or chronic UPR activation in these cells has
been shown to contribute to pancreatic β-cell loss in type I and type II diabetes.
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Additionally, antibody-producing B cells also require UPR signaling molecules.
IRE1 is required for B cell maturation and for development of immunoglobulin. This was
initially observed utilizing mice lacking XBP1. These mice do not make mature
immunoglobulin responses, indicating that B cell maturation and plasma cell
differentiation requires physiological activation of the IRE1-driven UPR pathway. IRE1α
is required for B cell immunoglobulin gene arrangement, B cell receptor formation, and
splicing XBP-1 for final differentiation, but IRE1α is not required for pro-B cells to arise.
When stimulated with lipopolysaccharide (LPS), B cells upregulated UPR-related genes,
likely to recruit aid to efficiently meet the demand to process and fold immunoglobulin
proteins for large-scale antibody secretion [95]. Although UPR activation is necessary to
maintain homeostasis and clearly plays a role in homeostatic processes, tight regulation
of the UPR is paramount for maintaining cellular health. Persistent activation of the UPR
is present in multiple diseases, including diabetes, cancer, and neurodegeneration [7072].

Unfolded Protein Response and Astrocytes
Typically, the UPR is activated transiently to restore homeostasis, however,
chronic UPR activation has been implicated in a wide variety of diseases affecting the
CNS (CNS) including, but not limited to, AD, MS, and prion disease, PD, and HD [96108]. Perturbations in astrocyte function are now implicated in nearly all neurological
diseases [9]. This highlights the importance of astrocytes in maintaining and directing
neurological integrity. However, the mechanisms by which cellular stressors initiate
astrocyte dysfunction that contributes to disease are not well understood. Recently, single
cell RNA sequencing (scRNAseq) revealed that subpopulations of astrocytes that are
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expanded during Experimental Autoimmune Encephalomyelitis (EAE) have increased
UPR signaling, suggesting that the UPR is associated with neuroinflammatory disease
[109]. Additionally, overexpression of spliced XBP1 in astrocyte-like glial cells in C.
elegans extends life span of the species [110]. Astrocytes express all the initiating
sensors of the UPR (IRE1, PERK, and ATF6) and express a unique ER stress sensitive
molecule, old astrocyte specifically induced substance (OASIS). Further, astrocytes are
largely resistant to aberrant ER stress-induced cell death, suggesting a unique role for
UPR signaling in astrocytes.

IRE1 in astrocytes
IRE1 signaling has been linked to cell death and inflammation in the CNS.
Evidence of active IRE1 signaling has been reported in post-mortem human tissue in
clinically confirmed cases of AD, HD, and glioma in addition to many mouse in vivo and
in vitro disease models. In an immortalized astrocytic cell line, SVGA, cells infected with
HIV-1 require IRE1 signaling to activate JNK and activator protein (AP) -1 to induce cell
death [111]. Further, nitric oxide (NO) has also been demonstrated to activate IRE1dependent signaling in human glioma cell lines. Treating human astrocytoma (CRT-MG)
cells with an NO donor and the ER stress inducer, thapsigargin, increased apoptosis that
coincided with IRE1 nuclease activity, IRE1/TRAF2 complex formation, and p-JNK1/2
levels, implying that treatment of NO subsequently activates the IRE1-α/TRAF2/JNK
pathway. IRE1 knockdown confirmed that intracellular NO affects IRE1-dependent
phosphorylation of CREB in human glioma cells [112]. Together, this suggests pathogenic
stimuli (viral infection and reactive nitrogen species) can activate the IRE1 arm of the
UPR and contribute to cell death in in vitro astrocytoma cell lines.
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In vivo evidence suggests that IRE1 signaling in astrocytes is associated with the
neurodegenerative diseases AD and MS. In brain tissue from AD patients,
phosphorylated IRE1 is increased and correlates with disease severity based on Braak
Staging, a pathology-based characterization of AD [100, 113, 114]. To investigate the
role of IRE1 in a mouse model of AD, IRE1 was deleted in the nervous system using
Nestin-cre and crossed with the 5XFAD genetic model of AD. Genetic deletion of the
RNase domain of IRE1 significantly reduced amyloid deposition and astrocyte activation.
Further, deficiency of IRE1 signaling improved synaptic function and long-term
potentiation, suggesting restored memory and learning capacity of the mice. This led to
the amelioration of disease hallmarks including Aβ1-42 production, amyloid plaque
deposition, and cognitive deficits. Additionally, deletion of IRE1 reduced astrogliosis,
based on GFAP staining, in the 5XFAD hippocampus. In this case, attenuation of gliosis
may be through a direct effect on astrocytes or due to reduced overall disease burden
[100]. Further AD studies are needed to delineate the astrocyte-specific contributions of
IRE1 signaling.
In a large pharmacogenetic screen to identify signaling pathways involved in
pathogenic neuroinflammation in MS, astrocytes were stimulated in vitro with TNF-α and
IL-1β, two cytokines known to be associated with the pathogenesis of EAE and MS. Here,
Wheeler et. al determined that IRE1 is phosphorylated and XBP1 was spliced, suggesting
activation of IRE1 signaling during astrocyte-mediated neuroinflammation. To confirm this
in vivo, this study used cell-specific lentiviral delivery of short hairpin (sh) – RNA targeting
the gene that encodes for IRE1 (ern1) to knockdown expression in astrocytes during
active EAE, which reduced disease severity. These studies demonstrated that abrogating
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expression of IRE1 under control of the astrocyte selective GFAP promoter ameliorated
EAE disease course and reduced inflammatory mediators produced by astrocytes [115].
This suggests that IRE1 signaling in astrocytes is pathogenic in the murine EAE model of
MS.
These studies, collectively, imply that IRE1 signaling in astrocytes can be activated
by various stimuli and that activated IRE1 can integrate with many signaling pathways
that promote inflammation or cell death.

PERK in astrocytes
Activated PERK signaling has been reported in a variety of neurological diseases
including AD, MS, prion disease, neurotropic viral infection, and ALS [98, 105, 116, 117].
Using immunocytochemistry to analyze brain tissue of human MS samples, the UPR
proteins GRP78, XBP-1, and CHOP were increased in acute MS lesions [118]. In models
of prion disease, neuronal cell lines were infected with PrP, the misfolded protein
associated with prion disease. Prion infected neurons were more susceptible to cell death,
and targeting PERK signaling in in vivo models of prion disease is protective [104, 105,
108]. Some reports show that prolonged expression of CHOP is pro-apoptotic, but this
has not directly been demonstrated in primary astrocytes or in vivo models [119, 120].
However, the Venezuelan Equine Encephalomyelitis Virus (VEEV) induces apoptosis of
the astrocyte-like glioblastoma cell line (U87Mg) through CHOP expression that is
activated by PERK [121]. PERK knockdown in primary astrocytes reduces viral load of
VEEV, but there is no difference in viral load between U87Mg cells with or without PERK
expression [122].
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Further, evidence of activated PERK signaling in astrocytes has been reported in
neuropathological studies of human AD and PD brains [98, 123]. Additional studies have
established that PERK is phosphorylated in glial cells in brains from tauopathy-associated
dementias [117]. In a 2014 study, Devi and Ohno examined the role of a hemizygous
PERK knockout crossed to the genetic AD model, 5XFAD. Genetic PERK ablation
reduces phosphorylated eIF2α and ATF4. PERK haploinsufficiency in 5XFAD mice
partially rescued memory loss in a behavioral fear conditioning model. These cognitive
improvements coincided with a reduction in amyloid-β plaque burden in hippocampal and
cortical regions of 5XFAD mice. Importantly, the maladaptive effects of PERK signaling
were specific to onset of AD; there were no measured cognitive changes in unaffected
PERK+/- mice compared to control animals [124].
In sporadic ALS and in the transgenic ALS mouse model that expresses mutant
superoxide dismutase (SOD)G93A, immunohistochemistry staining of spinal cords
demonstrated that many astrocytes, along with other cell types, expressed CHOP,
suggesting that PERK signaling is activated in astrocytes in ALS [116]. Another study
modeling ALS in mice demonstrated that astrocytes are activated, as quantified by GFAP
immunofluorescence staining. Here, mice expressing wild type human SOD, which has
been reported to spontaneously aggregate and model spontaneous ALS, were exposed
to the pharmacological N-linked glycosylation inhibitor (tunicamycin) to induce UPR
activation, which was shown to increase SOD1 aggregation. Importantly, wild type
littermates did not have a significant increase in GFAP staining upon tunicamycin
treatment [125]. This suggests that SOD aggregation and UPR activation enhance GFAP
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expression, which is associated with a reactive astrocyte phenotype, in a murine ALS
model.
Additionally, Vanishing White Matter Disease (VWM) demonstrates the importance
of downstream PERK signaling in astrocytes. VWM is a leukoencephalopathy in which
dysfunctional astrocytes are thought to drive pathogenesis [126]. VWM is caused by an
autosomal recessive mutations in eIF2B, which reduce function and cause prolonged
suppression of protein translation in response to stimuli that promote eIF2α
phosphorylation [127, 128]. This highlights a role for phosphorylated eIF2α-driven
translational repression in preserving astrocyte homeostasis and directly links signaling
components downstream of PERK to neurological disease.
To date, multiple reports link UPR-dependent PERK signaling in astrocytes to
inflammatory gene expression and/or neurotoxicity [103, 129-131]. ER stress-inducing
pharmacological agents thapsigargin and tunicamycin promote phosphorylation of eIF2α
in primary murine astrocytes. [103, 129, 132, 133]. A 2014 study demonstrated that gene
expression of inflammatory markers (IL-6, CCL2), astrocyte markers (GFAP, OASIS), and
ER stress-related genes (GRP78, CHOP, PERK, ATF4) are upregulated throughout the
course of EAE in brain and spinal cord tissue. Downstream markers of PERK activation
such as phosphorylation of eIF2α and CHOP expression are exhibited in thapsigargintreated astrocytes concomitantly with upregulation of IL-6, CCL2, and CCL20.
Additionally, ER stress augmented IL-6 expression induced by IL-6 or oncostatin M
(OSM) in a PERK-dependent fashion. This suggests that astrocytes may contribute to the
UPR and inflammatory response seen in CNS tissue during EAE. It is important to note
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that these inflammatory proteins are induced at the protein level even under conditions of
phosphorylated eIF2α, which functions to attenuate translation, demonstrating that these
proteins are translated during UPR activation [131].
PERK is an important driver of inflammatory gene expression in astrocytes in
response to ER stress. A partial (heterozygous) or complete (homozygous) genetic loss
of PERK in primary astrocytes was associated with a lower astrocyte-driven expression
of as IL-6, CCL2, and CCL20 analyzed by qPCR or ELISA. Further, primary astrocytes
treated with thapsigargin and a PERK inhibitor, GSK2606414, reduced production of
cytokines and chemokines measured by ELISA. This demonstrates that PERK activation
contributes to both transcriptional and translational activation of inflammatory mediators
in astrocytes [129]. Therefore, unresolved UPR activation may contribute to prolonged,
aberrant inflammatory activation via PERK signaling that may contribute to the nonresolving nature of neurological diseases.
Cytokines such as IL-6, which is driven by PERK activation in astrocytes rely on
JAK-STAT signaling to exert their effects. JAK-STAT signaling has been directly linked to
astrocyte-driven pathology in neurodegenerative and neurological diseases.
PERK signaling activates downstream signaling in a JAK1 dependent mechanism,
and inhibiting JAK1 kinase activity reduced ER stress-induced inflammatory gene
expression. Importantly, JAK1 inhibition does not impact all ER stress-induced gene
expression. Further, it has been shown that PERK activates JAK1 to drive a subset of
gene expression that is distinct from those induced by the JAK/STAT activating cytokine
OSM [133]. This demonstrates that UPR signaling modulates inflammatory responses in
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a manner distinct from traditional inflammatory signaling. Taken together, this evidence
suggests that PERK and JAK-STAT signaling in neurodegenerative disease models may
promote aberrant inflammation. Targeting PERK signaling in astrocytes may be a
mechanism to selectively attenuate immune responses in neurological diseases.
Targeting the UPR to selectively attenuate inflammation is supported by work in
other cell types. For example, UPR signaling in macrophages activates proinflammatory
cytokine signaling via the IRE1 pathway. Here, ER stress activates the nucleotide-binding
oligomerization domain-containing protein (NOD) 1/2 and sXBP1 in an IRE1 dependent
manner. Contrary to macrophages, PERK drives IL-6 expression in astrocytes. This
highlights that the UPR regulates inflammation using distinct mechanisms in different cell
types [134, 135]. ER stress-induced IL-6 production in astrocytes differs from
macrophages in that it requires PERK and JAK1 but is independent of IRE1 and nuclear
factor-κB (NF-κB) [129, 131]. Additionally, endothelial cells produce IL-6 in response to
ER stress, but here, this IL-6 expression is dependent on both ATF4 and sXBP1 [136].
ER stress induced IL-6 expression in astrocytes does not rely on ATF4 signaling, as
demonstrated using siRNA-mediated knockdown of ATF4 in primary astrocyte cultures
[133]. This illustrates the need for more careful investigations regarding the nuances of
UPR signaling in various cell types. For example, the UPR in the CNS literature focuses
heavily on neurons and oligodendrocytes, however, these findings may not apply to
astrocytes. Although astrocytes induce IL-6 and other inflammatory molecules in a PERKdependent fashion, this is not the case for other IL-6 family members. Importantly, ciliary
neurotrophic factor (CNTF) is downregulated upon ER stress induction in cultured
astrocytes [137]. This suggests trophic support from astrocytes can be restricted by the
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UPR. Indeed, it has been shown that ER stressed astrocytes lose trophic support for
neuronal synapse formation [103].
Collectively, multiple studies have demonstrated that PERK signaling promotes an
astrocyte-driven inflammatory response. Although inflammation provides a beneficial and
restorative role, chronic inflammation is thought to contribute to neurological disease.
PERK signaling in astrocytes may be a target to selectively attenuate damaging
inflammation while retaining beneficial inflammatory signaling in the CNS. Further studies
and conditional deletion of PERK and downstream signaling components in astrocytes
are needed to solidify the role in disease models.

ATF6 and OASIS in astrocytes
ATF6 and old astrocyte specifically induced substance (OASIS (CREB3L1)) are
bZIP transcription factors similarly activated in response to ER stress. OASIS is a
molecule primarily expressed in astrocytes in the CNS. Upon activation, it is transported
to the golgi apparatus, is cleaved, and the N-terminal domain promotes expression of
ERAD-associated genes [138]. ATF6 is activated (cleaved) in embryonal astrocytes
during differentiation suggesting a role for ATF6 in astrocyte development [139]. OASIS
is also important for astrocyte differentiation. In mice lacking OASIS, astrocyte
development was impaired. OASIS was shown to bind the promoter of glial cells missing
transcription factor 1 (Gcm1) and promote Gcm1 expression. Gcm1 may regulate GFAP
promoter methylation allowing transcriptional activation. The reduced expression of
Gcm1 in OASIS-/- mice may, in part, underlie the reduced astrocyte differentiation [139].
To date, few studies have been performed examining the role of ATF6 in astrocytes during
disease states. In a murine model of ischemic stroke, middle cerebral artery occlusion
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(MCAO), ATF6 knockout mice exhibited reduced infarct area as analyzed by the
metabolic stain triphenyl tetrazolium chloride (TTC). Concomitantly, ATF6α knockout
mice had reduced STAT3 activation and expression of GFAP in the ischemic area of the
brain 3 days post MCAO as measured by immunoblotting [140]. This study suggests that
ATF6α is protective during ischemia and ATF6α knockout is associated with reduced
GFAP expression.
OASIS activation has also been linked, in astrocytes, to AD disease mechanisms.
Apolipoprotein E (ApoE) is a protein involved in catabolizing triglycerides and the ApoE4
allele is strongly associated with the development of AD, although causal associations
between ApoE4 and AD are not fully known, reviewed in [141]. Primary astrocytes
expressing mutant APOE, to model human ApoE4, exhibit reduced ApoE expression and
increased UPR activation, including cleavage of OASIS and genes downstream of the
IRE1 and PERK pathways. This suggests that ApoE can induce cleavage of OASIS and
activate the UPR in astrocytes and promote neuronal toxicity [142]. Collectively, there are
limited studies on the role of ATF6 and OASIS, however, these studies demonstrate that
activation must be well-regulated for proper astrocyte function.

Non-cell autonomous effects of ER stressed astrocytes
In a 2017 study, Sprenkle et. al was the first to describe that astrocytes can
transmit ER stress to other cell types, a phenomenon that was previously described in
cancer cells and termed transmissible ER stress (TERS) [143, 144]. This suggested that
UPR activation in astrocytes can induce UPR signaling in neighboring cells. In this study,
astrocyte conditioned media (ACM) collected from astrocytes treated with the ER stressinducing agent thapsigargin or tunicamycin was transferred to HT-22 hippocampal
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neuronal cells. The cells that were exposed to thapsigargin treated ACM exhibited higher
gene expression and protein levels of GRP78, spliced XBP1, and CHOP, indicating that
astrocytes secrete a soluble factor that stimulates an ER stress response. Further, this
study showed that neurons experiencing ER stress also secrete a molecule that induces
ER stress in cultures of neurons, astrocytes, and microglia [132, 145]. This study
identified that UPR activation can be transmitted between cells of the nervous system.
These studies are consistent with previous work that demonstrated that ER stress is also
transmissible between cancer or myocardial cells and macrophages, which also respond
to ER stress by producing inflammatory molecules, albeit these mechanisms are distinct
from those identified in astrocytes [132, 144, 146]. ER stressed astrocytes, through a
PERK-dependent process, also increase microglial expression of IL-1β and IL-6 [131].
Independently of PERK, ER stressed astrocytes reduce microglial expression of arginase,
CD206 and insulin like growth factor 1 [129]. Together, these data indicate that in
response to ER stress, astrocytes can shift microglia to an inflammatory phenotype.
Additionally, Wheeler and colleagues demonstrated that XBP1 knockdown in astrocytes
decreases the number of monocytes that traffic to the CNS during EAE. Macrophages
that trafficked to the CNS during EAE in the GFAP-driven XBP1 knockdown had reduced
expression of inflammatory genes involved in IL-6 signaling, NF-κB signaling, and
chemokine signaling. Similarly, microglia in the astrocyte specific XBP1 knockdown had
reduced proinflammatory gene expression in comparison to EAE animals with XBP1
expression astrocytes [115].
Astrocyte conditioned media from healthy astrocytes is known to support
synaptogenesis [147-149]. To determine if UPR activation impacts the ability of astrocytes
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to support synapses, Mallucci and colleagues collected astrocyte conditioned media
(ACM) from thapsigargin-treated astrocytes. By immunostaining pre and post synaptic
terminals, ACM from UPR activated astrocytes was shown to reduce synaptogenesis.
Further, inhibiting PERK pharmacologically restored the ability of ACM to promote
synapse formation, suggesting that UPR activation via PERK inhibits astrocyte-mediated
neurotrophic functions. Further, this study tested if targeting PERK-eIF2α signaling in vivo
could be neuroprotective. Using mice that over express prion protein (PrP) and succumb
to prion infection. Astrocyte specific lentiviral overexpression of GADD34, an eIF2αspecific phosphatase, was markedly protective in prion-infected mice. GADD34
overexpression (to reduce PERK signaling) in astrocytes prevented neurodegeneration
in the hippocampus, had an increased number of pyramidal neurons, reduced astrocyte
reactivity based on morphology and GFAP staining, and extended the life span of these
mice in comparison to control PrP animals. This study shows both in vitro and in vivo that
UPR activation via the PERK pathway alters the transcriptome and secreted molecules
of astrocytes and this is linked to a reduction in neuronal synapse formation. (Smith et al.,
2020). These studies expand upon and corroborate the previous findings that PERK
inhibition is protective in prion infection [97, 99, 104, 105]. Further, this suggests that
UPR-activated astrocytes have pathogenic roles in prion infection and identifies PERK
signaling as a central driver in this process.
Consistent with the notion that astrocytes have a significant role in directing the
milieu of the inflammatory environment in the CNS, viral infections have also shown to
induce the UPR in astrocytes, leading to pathogenic non cell-autonomous astrocyte
dependent pathology. The HIV protein Tat has been shown to induce ER stress in
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astrocytes leading to GFAP-dependent neurotoxicity (Fan & He, 2016). Inflammation and
expression of the human endogenous retrovirus protein, syncytin-1, promote ER stress
in astrocytes in MS [150]. This study demonstrated that ER stress proteins were
upregulated in MS patient brains, along with the human endogenous retrovirus protein
(HERV) syncytin-1. Syncytin -1 induces splicing of XBP1 and leads to downstream
inflammation. These mechanisms were confirmed by transfecting primary human fetal
astrocytes with syncinctin-1. This induced splicing of XBP1, indicating that the IRE1
pathway is activated. Further, Nos2 was concomitantly upregulated and contributed to
oligodendrocyte toxicity in the EAE model. Together, this suggests that IRE1 signaling is
stimulated by the HERV protein syncytin-1 to initiate a sXBP1-dependent nitric oxide and
neuroinflammatory response.
Additionally, Zika virus has been shown to activate the UPR in astrocytes. ZIKV
infection of astrocytes caused an over expression of UPR-related genes BiP, XBP1,
CHOP, and growth arrest and DNA damage-inducible protein (GADD) 34, Under these
conditions, cell viability was decreased, RNA metabolism genes and micro-RNAs were
downregulated, however, astrocyte-derived soluble factors glial cell line-derived
neurotrophic factor (GDNF) and neuronal growth factor (NGF) were upregulated,
highlighting that some molecules were still being translated under ER stress conditions
[151]. However, these results are associated with UPR activation, and direct evidence for
the non-cell autonomous action of UPR signaling in astrocytes still requires investigation.
These results lay the groundwork for further studies examining the role of ZIKV and other
neurotrophic viral infections in astrocytes.
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In summary, astrocytes play a critical role at directing the overall CNS environment
due to their close physical and trophic connection to other CNS cells as well as blood
vessels. UPR activation is emerging as an important process by which astrocytes
influence the survival, activation and function of other CNS resident and infiltrating cells.

Conclusions
Astrocytes, the most populous glial cell, mount potent inflammatory responses and
have been shown to aberrantly contribute to neurological pathology. Critically, limited
therapies and cures exist for most neurological diseases. Therefore, it is logical to assume
that identifying novel therapeutic targets to regulate disease-associated signaling
cascades is vital for the design of effective treatments. Overall, due to the well-established
association of protein aggregation and accumulation in neurological disorders and the
recent advances in astrocyte biology, understanding how astrocytes experiencing ER
stress influence the CNS environment may be a critical link in understanding signaling
pathways that contribute to neurological dysfunction. Our overarching hypothesis is that
fine-tuning astrocyte mediated responses to cell stress may be beneficial in ameliorating
aberrant inflammation that worsens neurodegeneration. Here, we have studied the
mechanisms that link endoplasmic reticulum (ER) stress and inflammation to identify
novel therapeutic targets for neurodegenerative diseases.
The UPR has been studied in many disease states and cell types, however, the
cell-specific roles of the UPR in the CNS is a relatively emerging field. ER stress has been
primarily characterized in the CNS focusing on neurons and oligodendrocytes [130, 152].
As more studies are performed, it is evident that UPR activation has diverse roles in each
CNS cell type. For example, EAE is ameliorated by PERK activation in oligodendrocytes,
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but PERK knockdown in astrocytes had no effect on the development of EAE [115, 153].
Although the UPR is known to activate pathways that have been associated with
apoptosis, there is little evidence that UPR signaling in astrocytes induces cell death.
Instead, UPR-activated astrocytes are posited in a unique position to contribute to the
inflammatory environment of the CNS because astrocytes are the most populous glial
cell, can be neurotoxic, and direct CNS inflammation by promoting microglial activation
and leukocyte trafficking [154-156]. Inflammatory and reactive astrocytes are attributed
to neurotoxicity in many disease models. Understanding how astrocytes are fine-tuned to
produce these neurotoxic responses is of vital importance; neuronal loss cannot be
overcome and leads to motor and cognitive decline.
In this work, we identify that ER stress and astrocyte-driven gene expression
changes are linked by the protein JAK1. In response to ER stress, the PERK signaling
pathway of the UPR can drive JAK-STAT dependent inflammatory signaling. Further, we
have identified that JAK1 can utilize alternative transcription factors to initiate a distinct
set of gene expression. ATF4 is selectively expressed in response to cellular stressors,
including ER stress. We have identified that JAK1 and ATF4 interact, and that JAK1
knockdown inhibits ATF4 binding to promoter sequences, suggesting that JAK1 and
ATF4 cooperatively drive gene expression.
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Abstract
Neurodegenerative diseases are associated with the accumulation of misfolded proteins
in the endoplasmic reticulum (ER), leading to ER stress. To adapt, cells initiate the unfolded
protein response (UPR). However, severe or unresolved UPR activation leads to cell death and
inflammation. The UPR is initiated, in part, by the trans-ER membrane kinase PKR-like ER kinase
(PERK). Recent evidence indicates ER stress and inflammation are linked, and we have shown
that this involves PERK-dependent signaling via Janus Kinase (JAK) 1. This signaling provokes
the production of soluble inflammatory mediators such as interleukin-6 (IL-6) and chemokine CC motif ligand 2 (CCL2). We, therefore, hypothesized that JAK1 may control widespread
transcriptional changes in response to ER stress. Here, using RNA sequencing of primary murine
astrocytes, we demonstrate that JAK1 regulates approximately 10% of ER stress-induced gene
expression and is required for a subset of PERK-dependent genes. Additionally, ER stress
synergizes with tumor necrosis factor-α (TNF-α) to drive inflammatory gene expression in a JAK1dependent fashion. We identified that JAK1 contributes to activating transcription factor (ATF) 4dependent gene expression, including expression of the genes growth arrest and DNA damage
(GADD) 45α and tribbles (TRIB) 3 that have not previously been associated with JAK signaling.
While these genes are JAK1 dependent in response to ER stress, expression of GADD45α and
TRIB3 are not induced by the JAK1-activating cytokine, oncostatin M (OSM). Transcriptomic
analysis revealed that JAK1 drives distinct transcriptional programs in response to OSM
stimulation versus ER stress. Interestingly, JAK1-dependent genes induced by ER stress in an
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ATF4-dependent mechanism were unaffected by small molecule inhibition of JAK1, suggesting
that, in response to UPR activation, JAK1 initiates gene expression using noncanonical
mechanisms. Overall, we have identified that JAK1 is a major regulator of ER stress-induced gene
expression.

Introduction
Prevalent diseases including neurodegenerative disorders, cancer, obesity and diabetes
are associated with the accumulation of misfolded proteins in the endoplasmic reticulum (ER) [1].
Under normal conditions, molecular chaperones within the ER fold proteins, an essential step in
the maturation of proteins destined for membranes or secretion. Misfolded proteins can result
from a multitude of origins including inflammation, reactive oxygen species (ROS), or genetic
mutations [2, 3]. Misfolding can ultimately result in loss of protein function and deleterious effects
to the cell. In eukaryotes, the ER has an intricate monitoring system to ensure each protein is
properly folded before being exported to its ultimate destination. If a protein is misfolded,
mechanisms are in place to re-fold or degrade the aberrant polypeptide. However, when
misfolded proteins overwhelm these mechanisms, this results in a disruption of homeostasis,
referred to as ER-stress and activation of the unfolded protein response (UPR). The UPR is a
highly conserved stress response tasked with restoring homeostasis or initiating apoptosis [4].
The UPR is mediated by three ER transmembrane sensor proteins: inositol requiring
enzyme-1 (IRE1), protein kinase R-like ER kinase (PERK) and activating transcription factor
(ATF) 6. Under unstressed conditions, the molecular chaperone glucose regulated protein
(GRP78) interacts with and maintains each of these proteins in an inactive conformation. When
unfolded proteins accumulate, GRP78 is recruited away from these ER transmembrane proteins,
promoting oligomerization and conformational changes in PERK and IRE1, which then likely
interact with misfolded polypeptides initiating enzymatic activity [2, 4-7]. Once active, PERK
phosphorylates eukaryotic initiation factor 2α (eIF2α) to reduce protein translation and alleviate
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the influx of nascent polypeptides into the ER [8]. Concomitantly, the UPR promotes the activation
and/or expression of transcription factors such as ATF6, X-box binding protein 1 (XBP1) and
ATF4 to drive the expression of ER chaperones to restore function [2]. ER stress has been widely
studied in neurons because it is often associated with neuronal death in models of neurological
diseases. Increasing evidence indicates ER stress also affects astrocytes. Astrocytes are the
most populous glial cell and respond to external stimuli by promoting production of inflammatory
cytokines [9]. In previous studies, humanized ApoE4 and amyloid-β drive ER stress and astrocyte
dysfunction. α-synuclein and mutant LRRK2, associated with PD, work together to drive ER stress
and Ca2+ disruption in astrocytes [10]. Inflammation and expression of the human endogenous
retrovirus protein, syncytin-1, promote ER stress in astrocytes in MS [11]. Consistent with this,
our previous work has indicated that neuroinflammation and STAT3 phosphorylation concomitant
with ER stress in the MS mouse model of experimental autoimmune encephalomyelitis (EAE)
[12]. Additionally, we have recently shown that ER stress is transmissible between cells of the
CNS. We showed that neurons experiencing ER stress can alert neighboring cells, including
astrocytes, by inducing an ER stress response in those cells [13]. Together, these studies suggest
that astrocytes are impacted by ER stress in neurological diseases and may contribute to the
associated pathologies.
In addition, the UPR stimulates an inflammatory response to possibly alert neighboring
cells to an impending danger and to recruit immune cells [3, 13, 14]. However, this inflammation
may contribute to the pathology of diseases involving ER stress [3, 15, 16]. The UPR has been
linked to primary signaling molecules contributing to inflammation such as nuclear factor κB (NFκB), the mitogen activated protein kinase (MAPK) c-Jun N-terminal kinase (JNK), and simulates
an acute phase response [15]. The UPR has also been shown to promote the production of
cytokines and chemokines, including the pleiotropic cytokine, IL-6 [12, 17, 18]. Typically, IL-6
exerts its action by binding to its cell membrane receptor and activating a Janus kinase (JAK) and
39

signal transducer and activator of transcription (STAT) cascade to modulate gene expression [19].
We have previously shown a PERK-dependent mechanism of JAK1 activation leading to IL-6
production, uncovering another connection between ER-stress and inflammation [12].
The JAK-STAT pathway is an integral signal transduction pathway in modulating
inflammatory gene expression and immunological function [20]. Loss of function studies have
shown that the 4 JAKs (JAK1, JAK2, JAK3 and Tyk2) and 7 STATs (STAT1, STAT2, STAT3,
STAT4, STAT5a, STAT5b and STAT6) are essential for lymphoid development, T and B cell
development, erythropoiesis, defense against viral and bacterial infections, as well as neural
function [21, 22]. While the majority of effects elicited by JAK activation are attributed to the
activation of STAT proteins, JAKs also integrate with other signaling pathways including
phosphatidylinositol 3-kinase (PI3K) signaling and the MAPK pathway [23]. Furthermore, cell
stressors such as hypoxia, reactive oxygen/nitrogen species, and ER stress activate JAK
signaling through receptor-dependent and independent mechanisms [12, 24-26].
It is well established that JAK1 is required for responsiveness to interferons, the IL-6 family
of cytokines and IL-2, among others, as well as various forms of cell damage. Considering the
integral relationship between ER stress and inflammation, we hypothesized that JAK1 may also
be a critical signaling node controlling transcriptional changes in response to ER stress.
Consistent with this hypothesis, we have identified that JAK1 regulates approximately 10% of the
genes induced by ER stress. In addition to its traditional role downstream of cytokine receptors,
JAK1 modulates expression of a distinct subset of genes in response to ER stress.

Materials and Methods
Mice and Primary Cell Preparations
C57Bl/6, PERK floxed and CAGG-CreERTM mice were purchased from The Jackson
Laboratory and bred and housed in the animal facility at West Virginia University under the care
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of the animal resources program. Primary murine astrocytes were prepared as previously
described [27]. Astrocytes were cultured in Dulbecco's modified eagle medium (DMEM; Gibco)
with 10% fetal bovine serum (FBS; Atlanta Biologicals), 16 mM 4-(2-Hydroxyethyl)piperazine-1ethanesulfonic acid, N-(2-Hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid) (HEPES; Gibco),
1X non-essential amino acids (Corning), 2 mM L-Glutamine, 100 units/ml penicillin, 100 g/ml
streptomycin (Gibco), and 50 g/ml gentamicin (Lonza). Astrocytes were separated from
microglia by shaking at 200 RPM for 1.5 h. Cells were then trypsinized (0.05%, Gibco) for 5 min
at 37°C, collected in media and centrifuged for 5 min at 300g. Cells were then seeded into multiwell plates and stimulated after 48 – 72 h.
Antibodies and Reagents
Primary antibodies used were: Anti JAK1 (3344), JAK2 (3230), P-eIF2α (3398), eIF2α
(5324), P-STAT3 (9145), STAT3 (12640), Lysine-specific histone demethylase 1 (LSD1) (2184),
ATF4 (11815) from Cell Signaling; Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(MAB374) from Millipore; JAK1 (610231) from BD Transduction Laboratories; transferrin receptor
(TfR) H68.4 (13-6800) from Thermo Fisher; and CCAAT-enhancer-binding protein homologous
protein (CHOP) (sc-7351) from Santa Cruz. Cytokines used were: oncostatin (OSM) M and tumor
necrosis factor (TNF) – α from R&D systems. Thapsigargin and tunicamycin used were from EMD
Millipore and AZD1480 was supplied from Santa Cruz Biotechnology. Puromycin was supplied
from Fisher Scientific.
Immunoblotting
Cells were washed twice with phosphate buffered saline (PBS) and lysed with lysis buffer
(20 mM 2-Amino-2-(hydroxymethyl)-1,3-propanediol (Tris), pH 7.5; 150 mM NaCl; 2 mM
Ethylenediaminetetraacetic acid (EDTA); 2 mM Ethylene-bis(oxyethylenenitrilo)tetraacetic acid
(EGTA); 0.5% Nonidet P-40 (NP-40)) containing 1X phosphatase and protease inhibitor cocktail
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(Pierce) as previously described [28]. Protein concentrations were determined using the
bicinchoninic acid assay (Pierce). Equal amounts of protein from each sample were solubilized in
Laemmli sample buffer and heated for 5 min at 95°C. Proteins were separated by SDSpolyacrylamide gel electrophoresis, transferred to nitrocellulose, and the membranes were
blocked in 5% milk/tris buffered saline with tween-20 (TBST), followed by an overnight incubation
at 4°C with primary Ab diluted in 5% bovine serum albumin (BSA) or milk in TBST, according to
the manufacturer’s recommendation. Horseradish peroxidase-conjugated donkey anti-rabbit or
donkey anti-mouse (1:4000 dilution) secondary Ab (Jackson Immuno Research) were incubated
for 1 h at room temperature, followed by detection with enhanced chemiluminescence.
Membranes were imaged digitally using a ChemiDoc Touch (Biorad). Immunoblot images were
analyzed using ImageLab software (BioRad). When applicable, quantification of immunoblot
images were quantified by obtaining volumetric measurements in ImageLab.
qRT-PCR
RNA was isolated using 1 ml of TRIzol (Sigma-Aldrich) according to the manufacturer’s
instructions. RNA was quantified using a NanoDrop (NanoDrop Technologies), and 1 g of RNA
was used for cDNA synthesis using Moloney Murine Leukemia Virus reverse transcriptase
(Promega). The cDNA was analyzed by quantitative PCR performed using probe-based gene
expression assays (IDT or Themo Fisher) in a Stratagene MX3005P or Applied Biosystems Quant
Studio 3. Reactions were carried out in 20 L and analyzed using the ΔΔCt method.

Protein translation
Protein synthesis was estimated by measuring puromycin incorporation using a modified
method based on [29]. Briefly, cells were incubated with puromycin (5 µg/ml) for 5 min followed
by washing in cold PBS and lysed with lysis buffer. One microgram of protein was spotted in
duplicate or triplicate on nitrocellulose and allowed to dry. The membrane was then
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immunoblotted (dot blot) using an anti-puromycin antibody (Millipore) at 1:5000 dilution in 5%
milk/TBST. Dots were quantified using ImageLab software (Biorad).
RNA sequencing and Bioinformatics
RNA was quantified by Qubit fluorometer. RNA quality was assessed by Bioanalyzer Nano
chip. All RIN values were greater than 8. Libraries were built using 750 ng RNA and KAPA
stranded mRNA kit as per manufacturers protocol. The libraries were then quantified with the
Qubit and run on the Bioanalyzer using a High Sensitivity DNA chip to determine average size.
They were then pooled at an equimolar ratio and sequenced (paired end (PE) 100bp) on the
HiSeq 2500 at Marshall University. RNA seq was also performed externally by Genewiz. Analysis
was performed using CLC Biomedical Genomics Workbench and Ingenuity Pathway Analysis
(Qiagen). Non-coding or non-annotated genes were not included in analysis. Gene ontology was
analyzed using ShinyGO v0.60 http://bioinformatics.sdstate.edu/go/ [30]. Full data sets are
available at NCBI Sequence Read Archive (SRA) # SRP129889.
Immunoprecipitation
Protein lysates were collected in lysis buffer. Anti-rabbit Dynabeads (15 µl per sample,
Invitrogen) were coated with 1 µg of α-ATF4 antibody overnight. Beads with the α-ATF4 antibody
were washed with PBS with 0.1% BSA 3 times. Protein (750 µg) was then incubated with the
Dynabeads for 3 h and washed 2 times with 0.5% NP-40 lysis buffer and 2 times with PBS with
0.1% BSA. Protein was eluted by incubating the Dynabeads in 1X Laemelli Buffer at 95°C for 5
minutes.
Cellular Fractionation
Nuclear and cytoplasmic fractions were obtained by collecting cells in 0.05% NP-40 buffer
(10 mM Tris pH 7.4, 10 mM NaCl, 3 mM MgCl2, 1 mM EGTA, 0.05% NP-40 with 1X protease and
phosphatase inhibitors) and centrifuged at 2700 x g for 10 min at 4 °C. Supernatants were
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collected and centrifuged at 17,000 x g for 15 min at 4 °C to obtain cytoplasmic fractions. The
pellet containing nuclei was washed twice in 200 µl of wash buffer (5 mM HEPES, pH 7.4, 3 mM
MgCl2, 1 mM EGTA, 250 mM sucrose, 0.1% BSA, with 1X protease and phosphatase inhibitors).
The pellet was then resuspended in wash buffer and layered on top of 1 ml of 1 M sucrose (with
protease and phosphatase inhibitors), and centrifuged at 2700 × g for 10 min at 4 °C. The nuclear
pellet was washed in the 0.05% NP-40 lysis buffer. The nuclear proteins were extracted by
resuspending the pellet in nuclear extraction buffer (20 mM HEPES pH 7.4, 1.5 mM MgCl2, 0.2
mM EDTA, 10 mM β-glycerophosphate, 300 mM NaCl with 1X protease and phosphatase
inhibitor) and incubating on ice for 30 min. The nuclear fractions were subsequently centrifuged
at 17,000 g for 15 min at 4°C. The supernatant was saved as nuclear extract.
siRNA Transfections
Primary astrocytes were transfected with the indicated small interfering (si) RNA (50 pmols
per 35 mm well) using Lipofectamine RNAiMAX (Life Technologies) according to the
manufacturer’s protocol. Cells were used for experiments 48–72 h after transfection. The siRNAs
used in this study include Control (non-targeting) siRNA,

JAK1 siRNA #1 (sequence:

GCUCCGAACCGAAUCAUCA), JAK1 siRNA #2 (sequence: CACUGAUUGUCCACAAUAUTT),
JAK2 siRNA (sequence GGACUAUAUGUGCUACGAUTT), ATF4 siRNA #1 (sequence:
GCUGCUUACAUUACUCUAATT),

ATF4

siRNA

#2

(sequence:

GCCUAGGUCUCUUAGAUGATT).
ELISA
Culture supernatants (100 μL, undiluted) were collected and assayed by ELISA for murine
IL-6 (Biolegend) according to the manufacturer’s protocol.

Statistics
44

Data are the means of at least three independent experiments. Significance, indicated by
* where p < 0.05, was determined by one-way analysis of variance (ANOVA) with post
hoc analysis or by Student’s T test. RNA-seq significance was determined using Empirical
Analysis of Differential Gene Expression (EDGE) test [31, 32].
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Results
In this study, we have used primary murine astrocytes as a model to study the role
of JAK1 in the ER stress response. Astrocytes are resistant to the cytotoxic effects of
prototypical ER stress inducing agents but respond with a robust UPR and inflammatory
response [12], making them ideal to study signaling and gene expression without overt
cell death. We have previously shown that ER stress-induced IL-6 expression requires
PERK and JAK1 in astrocytes [12]. To extend these findings, we tested if JAK2 could also
regulate IL-6. We focused on testing JAK1 and JAK2 because other JAKs (JAK3 and
Tyk2) are lowly expressed in astrocytes [33]. As shown in Figure 2.1A, ER stress induced
by thapsigargin (thaps) drives production of IL-6 and siRNA-mediated knockdown of JAK1
abrogated ER stress-induced IL-6 production, while JAK2 knockdown had no effect in
comparison to the control (non-targeting) siRNA. Other JAK proteins, Tyk2 and JAK3, are
lowly expressed in astrocytes, suggesting they do not play an appreciable role in ER
stress-induced signaling [33]. Next, to understand how JAK1 affects ER stress-induced
signaling, we tested if JAK1 or JAK2 could modulate canonical PERK signaling. JAK1 or
JAK2 was knocked down in astrocytes, and the cells were exposed to thaps for 4 h to
induce ER stress. Knockdown of JAK1 and JAK2 was highly effective and selective, but
this had no significant impact on PERK-dependent eIF2α phosphorylation or CHOP
expression (Figure 2.1B). Because JAK2 had no effect on driving thaps-induced IL-6
production and did not affect the UPR signaling pathway, we chose to focus our studies
solely on JAK1. Moreover, eIF2α phosphorylation leads to translational repression, and
this is also unaffected by JAK1 knockdown (Figure 2.1C). JAK/STAT signaling drives
transcriptional changes, therefore, we tested if JAK1 could regulate expression of UPR
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Figure 2.1 JAK1 is required to drive ER stress-induced IL-6 expression and does
not affect canonical PERK signaling.
A. Primary astrocytes were transfected with control (CTL), JAK1, or JAK2 siRNA for 48
h and then treated with thapsigargin (thaps) (1 µM) for 24 h and analyzed by immunoblot
and ELISA. B. Astrocytes were transfected as in (A) followed by thaps (1 µM) treatment
for 4 h and analyzed by immunoblot. C. Astrocytes were transfected with CTL or JAK1
siRNA and treated with thaps (1 µM) for 90 min. In the last 5 minutes of treatment,
puromycin (5 µg/ml) was added to cultures. Cell lysates were analyzed by dot blot using
anti-puromycin antibody and quantified. UT = Untreated. D. Astrocytes were transfected
as in (A), treated with thaps (1 µM) for 4 h then analyzed by RT-qPCR. UT = Untreated.
E. Primary astrocytes were transfected with one of two distinct JAK1 siRNAs and treated
with thaps (1 µM), TNF-α (5 ng/ml), or both thaps and TNF-α for 4 h and analyzed by
RT-qPCR. N = 3. *p ≤ 0.05. Data are represented as means ± standard deviation.
signal transducers and ER chaperones. As shown in Figure 2.1D, ER stress increased
the expression of PERK, ATF6, and the oxidoreductase ER oxidoreductin-like beta
(Ero1lb) dependent on JAK1. These data indicate that JAK1 activation is dispensable for
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Figure 2.2 JAK1 regulates approximately 10% of ER stress-induced gene
expression.
A. Primary astrocytes were transfected with control (CTL) or JAK1 siRNA for 48 h followed by
treatment with thaps (1 µM) for 4 h and analyzed by RNA-seq. Volcano plots represent fold
change and p-values for approximately 25,000 expressed genes. B. Results were analyzed
as in (A) between thaps-treated samples without or with JAK1 knockdown. C. Principle
Component Analysis (PCA) of RNA-seq treatment groups. D. Venn diagram showing overlap
of genes upregulated in response to thaps treatment and downregulated by JAK1 knockdown
(left). Venn diagram of top 50 ER stress-induced genes overlapping with JAK1-dependent
genes (right). E. Functional classification of genes identified to be JAK1-dependent (Venn
diagram overlap – 51 genes) in response to ER stress using Ingenuity Pathway Analysis. The
number of JAK1-regulated genes in each pathway is indicated adjacent to each bar.

PERK dependent signaling that leads to translational repression, and imply a unique role
for JAK1 in the regulation of the ER stress response. UPR signaling has also been shown
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to augment already ongoing inflammatory responses, including NF-κB signaling [34-36].
To determine if JAK1 plays a role in mediating synergy between inflammatory and UPR
signaling, we treated astrocytes with thaps and the proinflammatory cytokine, tumor
necrosis factor (TNF) – α, which engages NF-κB signaling [37]. Here, we also chose a
second JAK1-targeting siRNA to corroborate our findings that this response is specific to
JAK1. We show that inflammatory gene expression (IL-6, CCL2, and CCL20) responds
in a synergistic manner to ER stress and TNF-α. Further, this synergy is JAK1 dependent,
highlighting the role of ER stress in influencing astrocyte-dependent inflammatory
responses. (Figure 2.1E). We have defined synergy here, as ER stress having a more
than additive effect on the TNF-α stimulated inflammatory response. Overall, these data
suggest that JAK1 drives transcriptional regulation during UPR activation in astrocytes.
These findings, with our previous work showing that JAK1 regulates IL-6, CCL2
and CCL20 expression, led us to hypothesize that JAK1 has an important role in
regulating the transcriptional response to ER stress [12]. To test this globally, we used
RNA sequencing (RNA-seq). Astrocytes were transfected with control or JAK1 siRNA
followed by treatment with thaps for 4 h. Global changes in the transcriptome were then
analyzed by RNA-seq. As shown in the volcano plot in Figure 2.2A, ER stress induces
transcriptional reprogramming including upregulation of the prototypical UPR genes
CHOP (ddit3), ATF4 and XBP1 (Figure 2.S1). When JAK1 was knocked down in ER
stressed cells, this appeared to change the expression of many genes when compared
to thaps alone based on t-test p-values (Figure 2.2B). These data suggested that both
ER stress and JAK1 had a significant impact on the overall gene expression profile. To
test this, we used principal component analysis (PCA) that revealed that each of the
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treatment groups had a unique expression profile, indicating that JAK1 regulates the
overall response to ER stress (Figure 2.2C). We next investigated the global impact of
JAK1 on ER stress-induced gene expression using stringent statistical analysis. We
identified all of the genes significantly (EDGE test p < 0.05) upregulated by 1.5 fold or
greater in response to ER stress. We then identified all the ER stress-induced genes that
are JAK1 dependent. These were genes significantly upregulated by ER stress and
significantly reduced by 1.5 fold or greater by JAK1 knockdown. Overall, more than 450
genes were increased by ER stress and approximately 10% of these genes were
regulated by JAK1 (Figure 2.2D). These data indicate that JAK1 has a significant (p =
2.01 x 10-14 by hypergeometric probability [38]) and unexpectedly large role in the
regulation of ER stress-induced gene expression. To examine the most strongly induced
genes, we identified the top 50 ER stress-induced genes (Figure 2.S1). This list included
well-established genes known to be robustly induced by ER stress including tribbles 3
(TRIB3), CHOP, and ATF3 [39]. We then compared this gene set to the ER stress induced
genes that are JAK1-dependent (Figure 2.S1). This identified CCL20, which we
previously identified as JAK1-dependent as well as many genes not previously associated
with JAK1 signaling. By comparing these two analyses, we identified that 15 (30%) of the
top 50 ER stress-induced genes are JAK1 dependent (Figure 2.2D). This is a highly
significant overlap (p = 6.14 x 10-21 by hypergeometric probability). These included
adrenomedullin 2 (Adm2), CCL20, Prostaglandin-endoperoxide synthase 2 (Ptgs2),
Nuclear Protein 1 (Nupr1) and Regulator of G Protein Signaling (RGS) 16 among others,
which have previously been shown to be induced by ER stress [12, 40-43]. To identify the
general pathways regulated by JAK1, we used Ingenuity Pathway Analysis (IPA). As
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Figure 2.3 JAK1 is required for full engagement of PERK-dependent gene
expression.
A and B. Astrocytes were isolated from PERKfl/fl mice without or with tamoxifen-inducible
cre (CAGG-CreERTM). Cells were treated with tamoxifen for 48 h to delete PERK fold by
thaps (1 µM) treatment for 4 h and RT-qPCR analysis. Astrocytes were transfected wit or
JAK1 siRNA #1 for 48 h, treated with thaps (1 μM) for 4 h, and analyzed by RT-qPCR. C.
Astrocytes were transfected with a second JAK1 siRNA, and ER stress was induced by
treating with thaps (1 µM) or tunicamycin (tunic) (5 µM) for 4 h, followed by RT-qPCR
analysis. Data are represented as means ± standard deviation. N = 3. *p ≤ 0.05.
shown in Figure 2.2E, growth arrest and DNA damage (GADD) 45α signaling and other
stress-responsive pathways, including the UPR, were significantly regulated by JAK1.
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These data indicate that JAK1 has a central role in the regulation of transcriptional
reprogramming induced by ER stress.
We have previously shown PERK-dependent activation of JAK1 [12]. Therefore,
we expected that JAK1 would be important for PERK-dependent transcriptional
responses. To test this, we selected several genes including IL-6 and CCL2 that we know
to be PERK and JAK1 dependent. We also selected, based on the RNA-seq data, the
DNA damage induced protein GADD45α and the pseudokinase TRIB3. As shown in
Figure 2.3A, ER stress induces the expression of IL6, CCL2, GADD45α, and TRIB3.
Genetic deletion of PERK significantly reduced ER stress induced expression of each of
these genes, indicating they are PERK dependent. JAK1 knockdown also significantly
suppressed each of these genes, indicating they are JAK1 dependent (Figure 3A).
Importantly, not all PERK-dependent gene expression relies on JAK1. As shown in
Figure 2.3B, ER stress-induced expression of ATF4, CHOP and the chemokine C-X-C
motif ligand 1 (CXCL1) are PERK dependent but are unaffected by JAK1 knockdown.
These data demonstrate that JAK1 is essential for full engagement of PERK-dependent
gene expression in response to ER stress. These data suggest, for the first time, that
GADD45α and TRIB3 are JAK1 dependent. GADD45α and TRIB3 are known to be
induced by ER stress, however, have not been previously associated with JAK-STAT
signaling. To confirm that ER stress upregulates GADD45α and TRIB3 expression in a
JAK1-dependent manner, we utilized a different ER stress-inducing agent (tunicamycin)
and a second distinct JAK1 siRNA. In Figure 2.3C, we corroborated that JAK1
knockdown reduces ER stress-induced expression of IL-6, GADD45α, and TRIB3,
providing further evidence that these genes are JAK1-dependent.
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Next, we tested if a JAK1-activating cytokine could also drive GADD45α and
TRIB3 expression. We used the IL-6 family cytokine, oncostatin M (OSM), which signals
through JAK1-STAT3-dependent mechanisms in astrocytes [33]. JAK1 siRNA
knockdown in astrocytes led to an abrogation of OSM-mediated phosphorylation of
STAT3, confirming the requirement of JAK1 (Figure 2.4A). Stimulation of astrocytes with
OSM induced a concentration-dependent increase of IL-6, as expected. However, OSM
had no effect on GADD45α or TRIB3 expression (Figure 2.4B). Next, we took a
transcriptome-wide approach to compare the set of JAK1-dependent genes in response
to OSM versus ER stress (Figure 2.2B). Here, we used RNA-seq to identify significantly
induced (EDGE test p value < 0.05) genes by OSM. These genes had a fold change of
1.5 or greater when compared to untreated samples. Next, we identified genes that were
significantly downregulated (EDGE test p value < 0.05, fold change < -1.5) with JAK1
knockdown. These criteria allowed us to identify the 183 OSM-induced JAK1-dependent
genes. We then compared the genes that are induced by ER stress and OSM in a JAK1dependent fashion. This revealed strikingly disparate gene expression profiles, with only
four genes in common (Figure 2.4C). The genes that are JAK1 dependent in response
to both OSM and ER stress are pentraxin 3 (Ptx3), nuclear protein 1 (Nupr1), Regulator
of G Protein Signaling (Rgs) 16, and chemokine (C-C motif) ligand (CCL) 7. These data
suggest that, in astrocytes, cytokines and ER stress induce distinct JAK1-dependent gene
expression changes. Next, we performed gene ontology analysis which assigns genes to
groups based on their molecular and functional characteristics previously defined in the
literature. Gene ontology showed JAK1 regulates gene expression corresponding to
different biological process depending on the stimulus (OSM or ER stress). (Figure 2.4D).
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OSM-induced JAK1 dependent genes generally induce immune and inflammatory related
genes. However, ER stress-induced JAK1 dependent genes are related to cell death and
apoptosis. This highlights that ER stress engages JAK1 to control a distinct transcriptional

Figure 2.4 ER stress induces a unique JAK1-dependent gene expression profile
that is distinct from OSM-induced JAK1-dependent gene expression.
A. Primary astrocytes were transfected with Control (CTL) or one of two distinct JAK1
siRNAs for 48 h and stimulated with OSM for 30 minutes followed by immunoblotting. B.
Astrocytes were stimulated with OSM at the indicated concentrations for 4 h. Gene
expression was measured by RT-qPCR. Data are represented as means ± standard
deviation. N = 3. *p ≤ 0.05. C. Astrocytes were transfected with CTL or JAK1 siRNA#2 and
treated with OSM (2.5 ng/ml) for 4 h. Gene expression was then measured by RNAseq to
identify the JAK1-dependent genes.Venn diagram of JAK1 dependent genes in response to
ER stress or OSM. D. Gene ontology analysis of the genes represented in (C).
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profile in comparison to the well-established role of JAK1 downstream of cytokine
receptors that we have modeled using OSM stimulation.

Figure 2.5 JAK1 and ATF4 cooperatively regulate a subset of ER stress-induced
genes.
A. List of genes that are both JAK1 and ATF4 dependent in response to ER stress as determined
by RNA-seq and reported by others. B. Astrocytes were transfected with control (CTL) or ATF4targeting siRNA for 48 h and treated with thapsigargin for 4 h. Indicated gene expression was
analyzed by RT-qPCR. UT = untreated. C. Astrocytes were transfected with CLT or one of two
JAK1 siRNAs and immunoblotted for ATF4. Immunoblots were quantified and normalized to
GAPDH expression. D. Astrocytes were transfected with CTL or JAK1 siRNA for 48 h and then
treated with thapsigargin for 4 h. Cytosolic and nuclear fractions were isolated and analyzed by
immunoblot. E. Primary astrocytes were treated with thaps (1 µM) for 4 h. Protein lysates
reserved or immunoprecipiated with α-ATF4 antibody before immunoblotting. F. Quantification
of JAK1 co-immunoprecipiated with ATF4 as shown in the top panel of (E). Data are represented
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as means ± standard deviation. N = 3. *p ≤ 0.05.

Previous work has shown that GADD45α and TRIB3 are ATF4 dependent [44, 45].
ATF4 is a transcription factor known to be induced by cell stress, including ER stress.
Expression of ATF4 is initiated downstream of PERK activation, requiring the
phosphorylation of eIF2α [46]. Further, we determined that many genes are regulated by
both JAK1 and ATF4 in response to ER stress and identified that 12 (out of 56) ER stressinduced JAK1-dependent genes have been previously reported as ATF4-dependent [40,
41, 47-51] (Figure 2.5A). To confirm that GADD45α and TRIB3 are ATF4-dependent, we
used siRNA to knockdown ATF4. As shown in Figure 2.5B, ATF4 knockdown abrogated
ER stress-induced GADD45α and TRIB3, but failed to reduce expression of IL-6,
consistent with our previous work [52]. These findings were confirmed using a second,
distinct siRNA targeting ATF4 (Figure 2.S2). This suggests that JAK1 and ATF4 may
cooperatively regulate gene expression. To determine if JAK1 regulated protein
expression of ATF4, we quantified ATF4 immunoblots of thaps-treated astrocytes with or
without JAK1 knockdown. JAK1 knockdown had no significant effect on ATF4 protein
levels in response to ER stress (Figure 2.5C). Previously, proteins related to JAK1 and
ATF4, JAK2, and CREB, respectively, have been shown to interact and translocate to the
nucleus [53]. Although JAK1 knockdown does not affect ATF4 expression, we next tested
if JAK1 expression is required for nuclear translocation of ATF4. We found that ATF4 is
expressed in the nucleus in response to thaps treatment independent of JAK1 expression,
indicating that JAK1 does not influence the expression or nuclear translocation of ATF4
(Figure 2.5D). Although JAK1 appeared in the nuclear fraction under these conditions,
analyzing cytosolic, nuclear, and plasma membrane markers indicated that the nuclear
fraction also contained plasma membrane (detected by the presence of transferrin
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receptor, Figure 2.S3). JAK1 is largely associated with the plasma membrane [54]. To
test if JAK1 and ATF4 physically interact, protein lysates from thaps-treated astrocytes

Figure 2.6 A subset of ER stress-induced JAK1-dependent signaling is
insensitive to kinase inhibition of JAK1.
A. Astrocytes were pretreated with JAK1/2 kinase inhibitor AZD1480 (1 µM) for 1 h before
0.5 h treatment with oncostatin M (OSM). Protein lysates were collected and analyzed by
immunoblot. B. Astrocytes were pretreated with AZD1480 for one hour and then treated with
thaps for 4 h. Gene expression was analyzed by RT-qPCR. Data are represented as means
± standard deviation. N = 3. *p < 0.05.

were immunoprecipitated using anti-ATF4 antibody and immunoblotted for ATF4 and
JAK1. Here, we found that JAK1 coimmunoprecipitates with ATF4, suggesting a physical
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interaction between these two molecules (Figure 2.5E & 2.5F). Altogether, these data
suggest that JAK1 and ATF4 cooperatively regulate ER stress-induced gene expressions.
The role of JAK1 to direct transcription factor activity in response to cytokines and
growth factors is well established to rely on tyrosine phosphorylation. JAKs phosphorylate
STATs to induce dimerization and translocation to the nucleus to initiate gene expression
[55]. Because we have shown that JAK1 and ATF4 regulate common genes and
coimmunoprecipitate, we hypothesize that ATF4 could be an alternative transcription
factor that JAK1 can phosphorylate to alter activity in response to UPR activation. To
determine if the kinase activity of JAK1 is necessary to promote ER stress-induced ATF4dependent gene expression, astrocytes were treated with the JAK1/2 kinase inhibitor
AZD1480 and thaps. As shown in Figure 2.6A, AZD1480 effectively abrogates OSMinduced phosphorylation of STAT3. Expression of known JAK1/STAT3-dependent genes
IL-6 and CCL2 were increased by thaps and kinase inhibition of JAK1 attenuated
expression of these genes (Figure 2.6B). However, GADD45α and TRIB3 were not
sensitive to JAK1 kinase inhibition (Figure 2.6B). These results imply that JAK1 elicits
noncanonical signaling in response to ER stress that may not rely on the kinase activity
of JAK1. These data suggest that JAK1, through physical interaction, can influence ATF4dependent gene expression.

Discussion
In this study, we have shown that JAK1 controls the expression of an unexpectedly
large number of genes in response to ER stress. Many of the genes regulated are
associated with inflammation, consistent with the critical and well-established role of JAK1
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in immune function [19, 20]. We and others have shown that UPR signaling integrates
with multiple pathways regulating inflammation [3, 13]. We have established that the
PERK-JAK1 axis drives inflammatory gene expression including IL-6 in murine astrocytes
and other cell types [12, 52] while IRE1 drives IL-6 through a nucleotide binding
oligomerization domain 1/2 (NOD1/2) dependent mechanism in macrophages and in the
periphery in vivo [18]. JAK1 also regulated genes involved in the ER stress response
including the key signal transducing molecules PERK and ATF6. Further, our previous
work has shown that JAK1 interacts with PERK and that PERK is phosphorylated by
JAK1. Our current work demonstrates that JAK1 is a critical mediator of PERK-dependent
gene expression but does not regulate phosphorylation of eIF2α or subsequent
attenuation of protein translation. These data suggest a reciprocal interaction in which
PERK drives JAK1 activation, which in turn, drives PERK expression. This work also
suggests that PERK-dependent activation of JAK1 and phosphorylation of eIF2α are
distinct signaling branches. While PERK appears to initially stimulate independent
pathways through JAK1 and eIF2α, we have shown that ER stress-induced IL-6, CCL2,
and CCL20 expression require both JAK1 and translational attenuation independent of
ATF4 [52]. Further, we have shown that JAK1 mediates synergistic gene expression
between ER stress and the proinflammatory cytokine TNF-α. Our findings, here, are
summarized in Figure 2.7. This is consistent with other reports that ER stress is able to
augment ongoing inflammatory responses [18, 56-58], and for the first time, have shown
that JAK1 is integral for this synergy in astrocytes. We have now identified that JAK1
modulates ATF4-dependent gene expression, indicating that JAK1 integrates at multiple
points downstream from PERK. In some contexts, ER stress has been reported to inhibit
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JAK/STAT signaling [59, 60]. However, additional studies are needed to determine if
JAK1 also drives noncanonical gene expression in those cell types and conditions.

Figure 2.7 Summary of ER stress-induced JAK1-dependent signaling.
Our current work demonstrates that JAK1 is a critical signaling node in response
to ER stress in astrocytes. However, we cannot distinguish if the JAK1-dependent effects
are immediate to ER stress signaling or result from basal regulation in the expression of
critical signaling molecules. The data indicate that JAK1 can drive stimulus-dependent
gene expression programs. We have shown that JAK1 dependent genes in response to
cytokine (OSM) stimulation is distinct from ER stress driven JAK1-dependent gene
expression. We show this JAK1 promoted the expression of genes such as GADD45α
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and TRIB3 in response to ER stress but not following cytokine stimulation. It is currently
unknown if this differential JAK1-dependent gene expression program is an adaptive
response or part of a maladaptive response to ER stress and potentially other pathogenic
stimuli. Moreover, pathway analysis implicated JAK1 in the regulation of several stressactivated pathways not investigated in the present study, such as sirtuin signaling,
PI3K/Akt signaling, aryl hydrocarbon receptor signaling, and protein ubiquitination
pathways (Figure 2.2E). JAK1 has broad involvement in mediating the biological actions
of many cytokines such as the IL-6 family, IL-10 family, and interferons [61-64].
Additionally, JAK1 inhibitors are under investigation for treatment of cancers and
autoimmunity [55]. However, this treatment may promote immunosuppression; upper
respiratory tract and urinary tract infections were among the most common side effects
reported in psoriasis patients using JAK1 inhibitors [65]. Therefore, a complete
understanding of the JAK1-dependent mechanisms induced by both cytokines and
cellular stress may provide broad insight into the mechanisms that underlie pathologyassociated signaling pathways.
The nature of the novel JAK1 signaling activity is currently unknown but, as we
have shown, may involve interaction with the stress-inducible transcription factor ATF4.
We have shown that JAK1 and ATF4 regulate many of the same genes in response to
ER stress and that JAK1 coimmunoprecipitates with ATF4. However, as suggested in
Figure 2.6, the JAK1-mediated regulation of ATF4 may not involve the well-characterized
kinase activity of JAK1. Although we used a kinase inhibitor of JAK1 that also inhibits
kinase activity of JAK2, we do not believe that JAK2 plays an appreciable role in regulated
ER stress-induced gene expression (Figure 2.1A). Expanded studies to confirm this
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kinase-independent interaction between JAK1 and ATF4 are currently underway. Other
potential mechanisms include JAK1 nuclear localization [66] and modulation of gene
expression or a structural/adaptor function to facilitate key signaling events such as the
activation of other transcription factors, like ATF4. JAK1 contains functional domains
including a FERM domain and a pseudokinase domain which may mediate important noncatalytic functions of JAK1 [67]. In models of diffuse large B cell lymphoma, others have
recently elucidated that JAK1 has a classical nuclear localization sequence between its
FERM and SH2 domains, demonstrating that JAK1 may influence transcriptional changes
using various mechanisms that are independent of STAT phosphorylation at the site of
cytoplasmic cytokine receptors [66]. Further, a noncanonical role for JAK1 has been
described in epigenetic modulation of gene expression. JAK1 has been shown to directly
phosphorylate the histone protein, H3, to promote STAT-independent gene expression
[68].
While we have revealed an important and previously unknown role for JAK1 in
response to ER stress, there are several caveats. First, this work was completed using a
single type of cultured cells (primary astrocytes) and high concentrations of
pharmacological agents to induce ER stress. It is unknown from these data if JAK1 has
a similarly important role in vivo under physiological conditions. These studies are
currently underway. Additionally, we focused on measuring gene expression at the mRNA
level because of the tools available for whole genome transcriptomics. Considering that
most translation is inhibited by ER stress-induced eIF2α phosphorylation [8], it is likely
that many of the transcripts we have measured are not translated into proteins.
Nonetheless, this transcriptional reprogramming may be important following resolution of
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ER stress and resumption of translation. Overall, our data indicate that JAK1 is a central
mediator of transcriptional reprogramming during ER stress.
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Supplementary Material
Table 2-1 Top ER stress induced JAK1 dependent genes.

Top 50 ER stress induced genes and full list of genes induced by ER stress in a JAK1dependent fashion.
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Figure 2.S2 Confirming that ATF4 is necessary for ER stress-induced
gene expression.
Astrocytes were transfected with control (CTL) or ATF4 siRNA #2 and treated
with thapsigargin (1 µM) for 4 h. Gene expression was analyzed by RT-qPCR.
Data are represented as means +/- standard deviation. N=3. *p < 0.05.

Figure 2.S3: Subcellular markers for cytosolic and nuclear isolation.
Astrocytes were transfected with control (CTL) or JAK1 siRNA #2 and treated
with thapsigargin (1 µM) for 4 h. Whole cell lysates, cytoplasmic, and nuclear
fractions were isolated and immunoblotted for various subcellular markers.
Transferrin receptor (TfR) is a plasma membrane marker. Glyceraldehyde 3phosphate dehydrogenase (GAPDH) is a cytoplasmic marker. Lysine-specific
histone demethylase (LSD) 1 is a nuclear marker.
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Abstract
Neurodegenerative diseases are heterogenous, have poor prognosis and limited
treatment options. Many neurological diseases are associated with protein misfolding and
inflammation. Accumulated unfolded or misfolded proteins in the endoplasmic reticulum
(ER) lumen results in ER stress. When ER stress occurs, the cell activates a conserved
adaptive response deemed the Unfolded Protein Response (UPR). The UPR is, in part,
activated by the protein kinase R (PKR) – like ER kinase (PERK). PERK is activated and
phosphorylates the eukaryotic initiation factor (eIF) 2α. Phosphorylated eIF2α selectively
attenuates translation to hinder nascent polypeptides entering the ER lumen to reduce
the protein folding demand in the ER. However, some proteins are selectively translated
under these conditions. This includes activating transcription factor (ATF) 4. Previously,
we have linked cellular stress initiated by protein misfolding to astrocyte-driven
inflammatory signaling that is dependent on Janus kinase (JAK) 1. We found that ER
stress induced noncanonical JAK1-dependent signaling that is distinct from cytokineinduced JAK1-dependent signaling. Further, we demonstrated that JAK1 and ATF4
coimmunoprecipitate, suggesting there is a physical interaction between these two
proteins. In the present study, we focused on understanding the mechanisms that drive
noncanonical JAK1-dependent signaling. We demonstrate that a portion of ER stressinduced JAK1-dependent gene expression does not rely on STAT transcription factors
and can utilize ATF4 as an alternative. Further, JAK1 is required for ATF4-promoter
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interactions in response to ER stress and JAK1 is expressed in the nucleus in these
conditions. Here, we have described a novel mechanism by which JAK1 controls ER
stress-induced signaling in astrocytes.

Introduction
Neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s
disease (PD), and Multiple Sclerosis (MS) are progressive diseases associated with
protein misfolding and inflammation [1-3]. It is now accepted that a properly functioning
immune system is paramount for normal neurological function, however, during
neurodegenerative states, aberrant and chronic inflammation may drive disease
pathology. Astrocytes contribute to the overall inflammatory milieu of the CNS. Astrocytes
are the most populous glial cell in the CNS and respond to insult or injury by producing
chemokines and cytokines including interleukin (IL) - 6, interferon (IFN) -γ, tumor necrosis
factor (TNF)-α, IL-1β, chemokines C-C motif (CCL) 2, CCL3, CCL20, among many others
[1, 4-7] that can promote activation of brain resident macrophages (microglia) and initiate
infiltration of peripheral immune cells to the CNS [8-10]. Many of the previously mentioned
cytokines and chemokines that astrocytes produce are dependent on the Janus Kinase
(JAK) – Signal Transducer and Activator of Transcription (STAT) pathway controls
signaling of many of these cytokines.
JAK-STAT signaling is a ubiquitous inflammatory signaling pathway that controls
the function of many cytokines and chemokines. There are four JAKs which are typically
associated with the cytoplasmic tail of cytokine receptors and are activated upon ligand
binding and oligomerization of the cytokine receptor. There are seven STATs (STAT1,
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STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6) that are recruited to the
phosphorylated cytokine receptors by recognizing phosphotyrosine residues using SH2
domains. STATs are then phosphorylated by JAKs to be activated and hetero- or homodimerize. This reveals a nuclear localization sequence (NLS). STATs then translocate to
the nucleus where they bind promoter regions to initiate gene expression of a wide variety
of inflammatory-related genes.
The critical activation of JAK-STAT signaling is the phosphorylation of JAKs on
their activation loop, catalyzed by the dimerization of cytokine receptors which increases
their intrinsic kinase activity of JAKs are trans- and auto- phosphorylated and the adjacent
cytokine receptors are phosphorylated which initiates downstream signaling and
transcriptional changes. However, we have previously shown a specific role for JAK1
signaling in response to endoplasmic reticulum (ER) stress in astrocytes, highlighting that
JAK-dependent signaling can be activated by cellular homeostasis disruption in addition
to cytokines [11-13]. Like inflammation, UPR activation is ubiquitous amongst
neurological diseases and has been proposed to drive pathogenesis [14]. The UPR is, in
part, activated by the protein kinase R like endoplasmic reticulum kinase (PERK) [15].
PERK, in response to misfolded proteins accumulate in the ER lumen,
phosphorylates the eukaryotic initiation factor (eIF) 2α. The UPR selectively attenuates
translation via phosphorylation of serine 51 on eIF2α [16]. Phosphorylation of eIF2α
inhibits the binding of methionyl tRNAs to the initiation complex, thereby inhibiting
translation [15, 17]. During ER stress, it is advantageous to attenuate translation in order
to eliminate nascent polypeptides that would enter the ER, reducing demand for protein
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folding. However, some proteins are selectively translated under these conditions.
Typically, proteins that are translated while the UPR is active are genes that encode for
protein chaperones that aid in protein folding mechanisms to help restore homeostasis
by limiting the demand on the ER [17]. Certain genes, like activating transcription factor
(ATF) 4 are selectively translated due to the presence of upstream open reading frames
(uORF) in the 5’ region of the ATF4 mRNA [18]. The ATF4 mRNA contains two uORFs.
Under conditions of phosphorylated eIF2α in response to cellular stress, “leaky scanning”
facilitates increased expression of ATF4 by allowing the ribosome to bypass the
regulatory uORFs [19]. If cellular homeostasis cannot be reached, the cell will initiate
apoptotic mechanisms. Some reports conclude that this is through ATF4-dependent
regulation of CHOP [20].
Previous work has shown that, in response to ER stress, PERK can directly bind
and activate JAK1. This initiates JAK1-STAT3 dependent activation of inflammatory
genes, such as interleukin (IL) – 6 as well as the chemokines chemokine CCL2 and
CCL20 [11, 12]. These studies provided the first evidence that UPR signaling can directly
initiate inflammatory responses in astrocytes. Other groups have demonstrated that UPRreactive astrocytes produce soluble inflammatory signaling molecules in a PERKdependent manner, and that targeting PERK signaling in astrocytes is protective in a
model of prion disease [21]. This work provides evidence that the UPR signaling in
astrocytes could be a mechanism to selectively attenuate pathogenic inflammation while
preserving the normal immune responses.
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Previously, we showed that JAK1 is a major driver of transcriptional adaptation to
ER stress. Approximately 10% of the ER stress-induced genes in astrocytes were
dependent on JAK1 [13]. A subset of these genes had not been previously associated
with JAK-STAT signaling. This included genes such as growth arrest and DNA-damageinducible protein (GADD45) α and tribbles (TRB) 3, which we found to be dependent on
both JAK1 and ATF4 [13]. In this study, we hypothesized that astrocytic JAK1 can use
additional transcription factors to modulate gene expression without STAT transcription
factors in response to ER stress. Here, we have demonstrated that JAK1 can utilize ATF4
as an alternative transcription factor under conditions of ER stress in addition to STATs.
Using immunoprecipitation, we identified that JAK1 binds ATF4 at a specific location, and
JAK1 is expressed in the nucleus. Further, using ChIP, we determined that JAK1
expression is necessary for ATF4 to bind transcription start sites.

Methods
CHIP
Primary astrocytes were isolated wild type mice and ER stress was induced using
1 µM of thapsigargin for 4 h. Cells were crosslinked and immunoprecipitated using an
isotype control (IgG) or anti-ATF4 antibody. DNA was eluted and RT-qPCR was
performed using primers designed to target the most-likely ATF4 binding regions of the
Tribbles3 promoter, based on previously published ChIP-seq data. DNA samples were
performed as described in panel. Reads were aligned to the mouse genome. Redundant
reads were removed. To determine DNA binding locations based on enrichment of reads
in a single location, peak calling was performed using Model-based Analysis of ChIP-seq
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(MACS) 3 algorithm. ChIP-seq data represented as a profile plot to read density across
all transcription start sites in the genome.
Mice and Primary Cell Preparations
C57Bl/6 mice were purchased from The Jackson Laboratory and bred and housed
in the animal facility at West Virginia University under the care of the animal resources
program. Primary murine astrocytes were prepared as previously described [22].
Astrocytes were cultured in Dulbecco's modified eagle medium (DMEM; Gibco) with 10%
fetal bovine serum (FBS; Atlanta Biologicals), 16 mM 4-(2-Hydroxyethyl)piperazine-1ethanesulfonic acid, N-(2-Hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid) (HEPES;
Gibco), 1X non-essential amino acids (Corning), 2 mM L-Glutamine, 100 units/ml
penicillin, 100 g/ml streptomycin (Gibco), and 50 g/ml gentamicin (Lonza). Astrocytes
were separated from microglia by shaking at 200 RPM for 1.5 h. Cells were then
trypsinized (0.05%, Gibco) for 5 min at 37°C, collected in media and centrifuged for 5 min
at 300g. Cells were then seeded into multi-well plates and stimulated after 48 – 72 h.
Antibodies and Reagents
Primary antibodies used were: Anti JAK1 (3344), JAK2 (3230), P-eIF2α (3398),
eIF2α (5324), P-STAT3 (9145), STAT3 (12640), Lysine-specific histone demethylase 1
(LSD1) (2184), ATF4 (11815) from Cell Signaling; Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (MAB374) from Millipore; JAK1 (610231) from BD
Transduction Laboratories; transferrin receptor (TfR) H68.4 (13-6800) from Thermo
Fisher; and CCAAT-enhancer-binding protein homologous protein (CHOP) (sc-7351)
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from Santa Cruz. Cytokines used were: oncostatin (OSM) M and tumor necrosis factor
(TNF) – α from R&D systems. Thapsigargin and tunicamycin used were from EMD
Millipore and AZD1480 was supplied from Santa Cruz Biotechnology. Puromycin was
supplied from Fisher Scientific.
Immunoblotting
Cells were washed twice with phosphate buffered saline (PBS) and lysed with lysis
buffer (20 mM 2-Amino-2-(hydroxymethyl)-1,3-propanediol (Tris), pH 7.5; 150 mM NaCl;
2 mM

Ethylenediaminetetraacetic

acid

(EDTA);

2 mM

Ethylene-

bis(oxyethylenenitrilo)tetraacetic acid (EGTA); 0.5% Nonidet P-40 (NP-40)) containing 1X
phosphatase and protease inhibitor cocktail (Pierce) as previously described [23]. Protein
concentrations were determined using the bicinchoninic acid assay (Pierce). Equal
amounts of protein from each sample were solubilized in Laemmli sample buffer and
heated for 5 min at 95°C. Proteins were separated by SDS-polyacrylamide gel
electrophoresis, transferred to nitrocellulose, and the membranes were blocked in 5%
milk/tris buffered saline with tween-20 (TBST), followed by an overnight incubation at 4°C
with primary Ab diluted in 5% bovine serum albumin (BSA) or milk in TBST, according to
the manufacturer’s recommendation. Horseradish peroxidase-conjugated donkey antirabbit or donkey anti-mouse (1:4000 dilution) secondary Ab (Jackson Immuno Research)
were incubated for 1 h at room temperature, followed by detection with enhanced
chemiluminescence. Membranes were imaged digitally using a ChemiDoc Touch
(Biorad). Immunoblot images were analyzed using ImageLab software (BioRad). When
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applicable, quantification of immunoblot images were quantified by obtaining volumetric
measurements in ImageLab.
qRT-PCR
RNA was isolated using 1 ml of TRIzol (Sigma-Aldrich) according to the
manufacturer’s instructions. RNA was quantified using a NanoDrop (NanoDrop
Technologies), and 1 g of RNA was used for cDNA synthesis using Moloney Murine
Leukemia Virus reverse transcriptase (Promega). The cDNA was analyzed by
quantitative PCR performed using probe-based gene expression assays (IDT or Themo
Fisher) in a Stratagene MX3005P or Applied Biosystems Quant Studio 3. Reactions were
carried out in 20 L and analyzed using the ΔΔCt method.
ChIP sequencing and Bioinformatics
Wild type astrocytes were transfected with control or JAK1 siRNA and treated with
thapsigargin and analyzed by CHIP-seq to characterize differential regulation of ATF4dependent transcription in response to JAK1 knockdown. IP and DNA isolation from
1x107 astrocytes per condition (N = 2). Library preparation and sequencing was
performed by Admera Health BioPharma Services. Reads were aligned to the mouse
genome. Redundant reads were removed. To determine DNA binding locations based on
enrichment of reads in a single location, peak calling was performed using model-based
analysis of ChIP-Seq (MACS) 3 algorithm.
Immunoprecipitation
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Protein lysates were collected in lysis buffer. Anti-rabbit Dynabeads (15 µl per
sample, Invitrogen) were coated with 1 µg of α-ATF4 antibody overnight. Beads with the
α-ATF4 antibody were washed with PBS with 0.1% BSA 3 times. Protein (750 µg) was
then incubated with the Dynabeads for 3 h and washed 2 times with 0.5% NP-40 lysis
buffer and 2 times with PBS with 0.1% BSA. Protein was eluted by incubating the
Dynabeads in 1X Laemelli Buffer at 95°C for 5 minutes.
siRNA Transfections
Primary astrocytes were transfected with the indicated small interfering (si) RNA
(50 pmols per 35 mm well) using Lipofectamine RNAiMAX (Life Technologies) according
to the manufacturer’s protocol. Cells were used for experiments 48–72 h after
transfection. The siRNAs used in this study include Control (non-targeting) siRNA, JAK1
siRNA #1 (sequence: GCUCCGAACCGAAUCAUCA), JAK1 siRNA #2 (sequence:
CACUGAUUGUCCACAAUAUTT),

JAK2

siRNA

(sequence

GGACUAUAUGUGCUACGAUTT),

ATF4

siRNA

#1

(sequence:

GCUGCUUACAUUACUCUAATT),

ATF4

siRNA

#2

(sequence:

GCCUAGGUCUCUUAGAUGATT).
Statistics
Data are the means of at least three independent experiments. Significance,
indicated by * where p < 0.05, was determined by one-way analysis of variance (ANOVA)
with post hoc analysis or by Student’s T test. RNA-seq significance was determined using
Empirical Analysis of Differential Gene Expression (EDGE) test [24, 25].
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RNA Seq and Gene ontology
RNA was quantified by Qubit fluorometer. RNA quality was assessed by
Bioanalyzer Nano chip. All RIN values were greater than 8. Libraries were built using 750
ng RNA and KAPA stranded mRNA kit as per manufacturers protocol. The libraries were
then quantified with the Qubit and run on the Bioanalyzer using a High Sensitivity DNA
chip to determine average size. They were then pooled at an equimolar ratio and
sequenced (paired end (PE) 100bp) on the HiSeq 2500 at Marshall University. RNA seq
was also performed externally by Genewiz. Analysis was performed using CLC
Biomedical Genomics Workbench and Ingenuity Pathway Analysis (Qiagen). Non-coding
or non-annotated genes were not included in analysis.
Subcellular Cell Fractionation
To isolate whole cell lysate, nuclei, and cytoplasmic fractions, cells were
washed with PBS and collected in nuclei wash buffer (5 mM HEPES pH 7.4, 3 mM MgCl2,
1 mM EGTA, 250 mM sucrose, 0.1 % BSA with protease and phosphatase inhibitors).
Cellular contents were fractionated using nitrogen cavitation. Briefly, cell lysates were
placed in a nitrogen cavitation device pressurized to 200 psi and incubated on ice for 5
minutes before releasing contents. Whole cell lysate was collected at this step and
processed with 2X RIPA buffer. Cytosol was separated from nuclei by centrifugation
(2,700 g for 5 minutes). Nuclei was isolated using nuclear extraction buffer (20 mM
HEPES, 1.5 mM MgCl2, 0.2 mM EDTA, 100 mM β-glycerophosphate, 300 mM NaCl with
protease and phosphatase inhibitors).
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Results
Here, we investigated the mechanisms by which JAK1 controls the transcriptional
adaptation to ER stress in astrocytes. We previously identified JAK1 as a major driver of
ER stress-induced inflammation, demonstrating that JAK-STAT signaling functions

Figure 3.1 JAK1 kinase inhibition does not ablate most JAK1-dependent gene
expression in response to ER stress.
A) Primary astrocytes were transfected with control or JAK1 siRNA for 48 h. AZD1480
(2 µM) was added to cells transfected with control siRNA 1 h before thapsigargin (1 µM)
treatment (4 h). RNA was isolated and sequenced. B) Primary astrocytes were
transfected with control or JAK1 siRNA for 48 h. AZD1480 (2 µM) was added to cells
transfected with control siRNA 1 h before OSM (2.5 ng/ml) treatment (4 h). RNA was
isolated and sequenced. C) Gene ontology (GO) was performed on the ER stressinduced, JAK1-dependent genes as well as the ER stress-induced, AZD1480 inhibited
genes. Top 5 most significant GO groups are shown. D) Gene ontology (GO) was
performed on the ER stress-induced, JAK1-dependent genes as well as the OSMinduced, AZD1480 inhibited genes. Top 5 most significant GO groups are shown.
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outside of its traditional role downstream of cytokine receptors. Previously, we showed
that JAK1 controls approximately 10% of ER stress-induced gene expression in primary
astrocytes, including inflammatory genes such as IL-6 and chemokines CCL2 and CCL20
as well as ER stress-related genes that had not previously been associated with JAK1
signaling such as GADD45α and TRIB3. We showed ER stress related genes that are
dependent on both JAK1 and on ATF4 expression are insensitive to JAK1 kinase
inhibition using a pharmacological agent that targets JAK1 and JAK2 kinase activity,
AZD1480. Based on these findings, we wanted to determine if there were more genes
that were ER stress-induced in a JAK1-dependent fashion that were not reduced by
inhibiting the kinase activity of JAK1. To test this using an unbiased approach, we used
bulk RNAseq to determine the number of ER stress induced JAK1 dependent genes that
are sensitive to inhibition by the JAK1/2 kinase inhibitor AZD1480. We performed
differential gene expression on untreated and thapsigargin treated groups as well as on
thapsigargin and JAK1 siRNA thapsigargin treated groups from our previously published
dataset [13]. The overlapping genes were compared to differential gene expression of
thapsigargin and AZD1480 thapsigargin treated genes. Surprisingly, we found that
expression of most ER stress induced JAK1 dependent genes cannot be reduced by
inhibiting JAK1 with AZD1480. Only 4 of the 50 total genes were ER stress induced and
inhibited by AZD1480 (Figure 3.1A). We compared these results to the transcriptome of
oncostatin M (OSM) stimulated astrocytes. OSM is an IL-6 family cytokine that signals
through gp130 in a JAK1-STAT3 dependent manner [26]. Astrocytes robustly express the
OSM receptor [27]. In contrast to the thapsigargin stimulated astrocytes, we found that
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expression of the majority of the OSM-induced JAK1 dependent genes can be reduced

Figure 3.2 ER stress-induced gene expression does not require STAT3.
A) Primary astrocytes were treated with thapsigargin (1 µM) for 4 h. RNA was isolated and
sequenced. RPKM values for 3 technical replicates is shown. B) Primary astrocytes were
transfected with control (CTL), STAT1, or STAT1 and STAT3 siRNA for 48 h and treated with
IFN-γ (10 ng/ml) for 0.5 h. Protein lysates were collected and evaluated by immunoblotting. C)
Primary astrocytes were transfected with control (CTL), STAT3, or STAT1 and STAT3 siRNA
for 48 h and treated with OSM (2.5 ng/ml) for 0.5 h. Protein lysates were collected and
evaluated by immunoblotting. D) Primary astrocytes were transfected as in (B) and (C) using
STAT1 and STAT3 siRNA. Cells were treated with thapsigargin (1 µM) for 4 h. RNA was
collected for analysis via RT-qPCR. N = 3.

using AZD1480 (Figure 3.1B). Overall, less than 20% of the ER stress induced genes
can be inhibited using AZD1480 compared to approximately 80% of the OSM induced
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genes. Further, we performed gene ontology on the ER stress induced genes that are
downregulated using JAK1 siRNA and the genes that are downregulated using both JAK1
siRNA and AZD1480. Here, the top 3 gene ontology groups are different for each group.
Expectedly, the genes that are sensitive to inhibition to AZD1480 belong to gene ontology
groups related to immune processes. The ER stress-induced JAK1-dependent genes
belonged to functional gene ontology categories that include type I interferon signaling
and the unfolded protein response, as anticipated (Figure 3.1C). The ER stress-induced,
AZD1480-inhibited genes do not belong to these categories. Further, the OSM-induced
JAK1-dependent genes and OSM-induced AZD1480-inhibited genes belong to functional
gene ontology categories associated with inflammatory and immune signaling. This is in
line with the well-established role of JAK1-dependent gene expression. This suggests
that JAK1 utilizes different signaling mechanisms to regulate gene expression using
different stimuli.
JAK-STAT signaling is well-established to rely on JAK-mediated tyrosine
phosphorylation of STATs. Phosphorylated STATs dimerize to form an active
transcription factor complex. We found that most of the ER stress-induced genes cannot
be inhibited by targeting JAK kinase activity. Therefore, this led us to hypothesize that
JAK1 can regulate a subset of gene expression, in response to ER stress activation,
without STAT proteins.
To test if ER stress induced JAK1 dependent genes require STAT expression, we
first analyzed basal expression of STATs in astrocyte cultures by RNAseq. STAT3 is wellestablished to contribute to JAK-STAT signaling in astrocytes [28-32]. We confirmed via
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RNAseq that STAT3 is the most highly expressed STAT in astrocytes and is induced by
thapsigargin (Figure 3.2A). We proceeded to knockdown STAT1 and STAT3 in primary
astrocytes using siRNA and treated with thapsigargin for 4 h and analyzed gene
expression of JAK1 and ATF4 dependent genes. We knocked both STAT1 and STAT3

Figure 3.3 JAK1 and ATF4 interact between amino acids 248 and 275 of ATF4,
and this interaction does not require ER stress.
A) Graphical representation of ATF4 truncation mutants. B) Primary astrocytes were
transfected with 6 ug of full length ATF4 or truncated mutants of ATF4 using lipofectamine
3000 for 48 hours. Protein lysates were collected and immunoprecipitated using a JAK1targeting antibody and immunoblotted for ATF4 using 2 ATF4 antibodies with different
epitopes to detect all ATF4 mutants. C) Primary astrocytes were transfected with wild type
ATF4 vector as in (B) or treated with thapsigargin for 4 h. RNA was isolated and used for RTqPCR analysis.

down simultaneously because previous reports demonstrate that STAT1 and STAT3 can
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compensate for the expression of the other. STAT1/3 knockdown effectively eliminates
the STAT1 and STAT3 protein expression, as shown my immunoblotting (Figure 3.2B,
C). Interestingly, we found that STAT1/3 knockdown did not reduce thapsigargin-induced
expression of IL-6, GADD45α, or TRIB3, suggesting that JAK1 regulates genes in
response to ER stress without utilizing STAT transcription factors (Figure 3.2D).
We determined that STAT3 is not necessary for expression of JAK1-dependent
genes in astrocytes in response to ER stress. Therefore, we hypothesized that JAK1 can
utilize alternative transcription factors under conditions of cellular stress. Our previous
studies found that JAK1 and the transcription factor activating transcription factor (ATF)
4 coimmunoprecipitate under conditions of ER stress. ATF4 is selectively translated
under conditions of phosphorylated eIF2α. It is possible that JAK1 is driving gene
expression via ATF4 specifically under conditions of ER stress because ATF4 is not
basally expressed and JAK1 would not have the opportunity. To expand upon these
findings, we utilized vectors to express ATF4 truncation mutants to determine specifically
where JAK1 binds ATF4. We expressed the ATF4 mutants in primary astrocytes in vitro
and used JAK1 immunoprecipitation strategies. Here, we expressed the wild type, full
length ATF4, amino acids 1 – 275 of ATF4, amino acids 111 – 248 of ATF4, and amino
acids 248 – 351 (Figure 3.3A). Importantly, there is no induction of ER stress in these
conditions. ATF4 is expressed lowly at basal conditions, therefore, there should be little
contribution of the endogenous ATF4 protein in these samples. These vectors were
expressed in primary astrocytes and, using immunoprecipitation for JAK1, we identified
that JAK1 bound all four of the ATF4 mutants. Because of this, we infer that JAK1 binds
ATF4 in a location between amino acids 248 and 275 (Figure 3.3B). Importantly, this also
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implies that ER stress is not necessary for the JAK1 and ATF4 interaction. To determine
if ATF4 expression alone is sufficient to induce gene expression of JAK1 and ATF4dependent genes, we overexpressed wild type ATF4 in primary astrocytes or treated
astrocytes with thapsigargin for 4 h. This demonstrates that ATF4 expression is sufficient
to induce gene expression of TRIB3, however, at a lower magnitude than thapsigargin
treatment (Figure 3.3C). We hypothesized that this physical interaction leads to ATF4dependent gene expression in response to ER stress and that JAK1 binding is essential
for ATF4 to be recruited to promoters in a gene-specific fashion. However, these findings
were surprising because JAK1 has been reported to be constitutively associated with
cytokine receptors and ATF4 should be expressed in the nucleus where it drives
transcription.
To determine the subcellular localization of the JAK1-ATF4 interaction, we treated
primary astrocytes with thapsigargin for 4 hours to induce expression of ATF4 and then
isolated whole cell lysates (WCL), cytosol, and nuclei protein lysates from these cells.
We immunoblotted each subcellular fraction and confirmed selectivity of these fractions
by blotting for the Transferrin Receptor 1 (TfR1) as a plasma membrane marker,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a cytosolic marker, and lysinespecific histone demethylase (LSD) 1 as a nuclear marker. Then, we determined the
location of ATF4 and JAK1. ATF4 is exclusively expressed in the nucleus. JAK1 was
detected in each fraction, indicating that JAK1 is not exclusively associated with the
plasma membrane, as some studies have suggested [33] (Figure 3.4A). However, recent
reports have also suggested that JAK1 is expressed in the nucleus [34, 35], corroborating
our findings. Further, we quantified these immunoblots. In response to thapsigargin
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treatment and induction of ER stress, less JAK1 is in the cytosol and there is an increase
of

Figure 3.4 JAK1 is expressed in the nucleus in response to ER stress.
A) Primary astrocytes were treated with thapsigargin (1 µM) for 4 h.
Nuclear isolates were isolated via nitrogen cavitation. Whole cell lysates
(WCL), cytoplasm (cyto), and nucleus (nuc) were collected and
immunoblotted. B) Three immunoblots were quantified. ATF4 protein
expression was normalized to expression of either GAPDH (for WCL and
cyto) or to LSD1 (for nuclear lysates). C) Three immunoblots were
quantified. JAK1 protein expression was normalized to expression of either
GAPDH (for WCL and cyto) or to LSD1 (for nuclear lysates).
JAK1 in the nucleus (Figure 3.4B). This suggests that JAK1 may be translocating to the
nucleus in response to ER stress and/or is sequestered in the nucleus by ATF4. Overall,
these data suggest that JAK1 and ATF4 are interacting in the nucleus. We hypothesized
that this interaction between JAK1 and ATF4 drives ATF4-dependent gene expression in
response to ER stress.
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Figure 3.5 JAK1 is required for ATF4-promoter interactions.
A) Primary astrocytes were isolated wild type mice and ER stress was induced using 1
µM of thapsigargin for 4 h. Cells were crosslinked and immunoprecipitated using an
isotype control (IgG) or anti-ATF4 antibody. DNA was eluted and RT-qPCR was
performed using primers designed to target the most-likely ATF4 binding regions of the
Tribbles3 promoter, based on previously published ChIP-seq data. (B) DNA samples
were performed as described in panel (A). Reads were aligned to the mouse genome.
Redundant reads were removed. To determine DNA binding locations based on
enrichment of reads in a single location, peak calling was performed using Model-based
Analysis of ChIP-seq (MACS) 3 algorithm. (C) ChIP-seq data represented as a profile
plot to read density across all transcription start sites in the genome.
To test this hypothesis, we expanded our studies to determine the impact of JAK1
on ATF4-dependent gene expression on a genome wide level. We used ChIP-seq to
characterize differential regulation of ATF4-dependent transcription in response to JAK1
knockdown. We used primary astrocytes with control (CTL) or JAK1 targeting siRNA and
treated with (or without) thapsigargin. We crosslinked the cells and immunoprecipitated
using an isotype control (IgG) or α-ATF4 antibody. To identify how JAK1 influences ATF4
binding, we compared the mapped chromatin locations in the ER stress-treated condition
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in comparison to an untreated control to determine ATF4 DNA binding locations in
response to ER stress. We then compared these mapped DNA sequences to a JAK1
knockdown ER stress treated group. Here, we were able to identify locations in the
genome where JAK1 knockdown interrupts ATF4 binding. ATF4 is not basally expressed.
Therefore, as expected, ChIP targeting ATF4 resulted in low numbers of mapped reads
in both the isotype control samples as well as the untreated samples where ATF4
expression is not stimulated. Thapsigargin treated groups had much higher reads, as
expected. We then performed motif analysis this demonstrated that much of the
sequenced DNA included the known ATF4 DNA binding motif, suggesting that ChIP
successfully selected for ATF4-bound DNA sequences (Figure 3.5A). These analyses
suggest that JAK1 is required, globally, for ATF4-promoter interactions (Figure 3.5B). To
test this empirically, we detected via ChIP-qPCR that ATF4 is recruited to the promoter
of TRIB3, a gene that we have demonstrated to be induced upon ER stress in astrocytes
and that is dependent on both JAK1 and ATF4. JAK1 knockdown interrupts the ability of
ATF4 to bind the TRIB3 promoter, suggesting that JAK1 is required for ATF4 to bind the
TRIB3 promoter (Figure 3.5C). Overall, these data suggest that JAK1 is required for
ATF4 to bind promoter regions and drive gene expression in astrocytes in response to
ER stress.

Discussion
This study has identified a novel role for JAK1 signaling in response to cellular
stress in astrocytes. To our knowledge, this is the first study to demonstrate that JAK1
can initiate gene expression using transcription factors in addition to STATs. Here, we
have identified that JAK1 interacts with ATF4. The interaction between JAK1 and ATF4
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is necessary for ATF4 to bind transcription start sites and regulate gene expression in
astrocytes. ATF4 is lowly expressed at basal conditions, therefore, under conditions of
low phosphorylated eIF2α, JAK1 would be expected to drive gene expression primarily
through STATs. However, we suggest that ER stress, which induces high levels of eIF2α
phosphorylation, provides JAK1 with the opportunity to modulate gene expression using
additional transcription factors, like ATF4. For example, PERK-mediated phosphorylation
of eIF2α is one part of the integrated stress response (ISR). There are other eIF2α
kinases that are activated upon limited heme availability, viral infection, or limited amino
acid deprivation. ATF4 overexpression is sufficient to induce expression of TRIB3, without
ER stress (Figure 3.3C). The interaction between JAK1 and ATF4 is dependent on ATF4
expression, not ER stress (Figure 3.3B). Therefore, we anticipate that other types of cell
stress that induce ATF4 would also be regulated by JAK1. This is currently the scope of
ongoing studies.
ATF4 is expressed in many CNS cells [27] and has been reported to impact
neurological behavior and is implicated in neurodegenerative disease [36]. For example,
ATF4 is upregulated in the substantia nigra in some Parkinson’s disease (PD) patients.
In the same study, cultured neurons are protected from toxin-induced neurotoxicity by
overexpressing ATF4. This suggests that ATF4 may be protective by promoting
dopaminergic neuron survival in PD [37]. In in vivo mouse models and in post-mortem
brain tissue of AD patients demonstrates an upregulation of ATF4 [38, 39]. Further, ATF4
deficient mice are protected against ALS progression in mutant SOD1 transgenic animals
[40]. ATF4 is also necessary for normal synaptic plasticity and memory in hippocampal
neurons [41, 42]. Taken together, this suggests that ATF4 plays an important role in
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proper neuronal function, however, there is a paucity of studies that focus on the cellspecific contribution of ATF4-regulated gene expression.
Here, we provide evidence that JAK1 uniquely controls gene expression in
astrocytes in response to ER stress. Further, JAK1 is required for ATF4 to bind promoter
regions and regulate gene expression. We determined this by performing ChIP-seq on
primary astrocytes. Previously, ATF4 ChIP studies have been completed using
immortalized cell lines and have not been completed in CNS cells. Most of the ATF4
target genes in the CNS that have been unveiled have relied heavily on in vitro systems.
Therefore, in vivo models of neurodegenerative disorders using conditional ATF4
knockouts are needed to solidify the role of ATF4 in these diseases.
There are currently 3 FDA approved pharmacological agents that target activation
of JAK1 and additional inhibitors undergoing clinical trials. These inhibitors target the
kinase activity of JAK1. In this study, we have unveiled a role for JAK1 that does not
require JAK1-mediated phosphorylation of STATs. Therefore, we would anticipate that
JAK1 inhibitors in patients would not impact ATF4-dependent gene expression. For
example, we hypothesize that patients on JAK1-targeting drugs would not have altered
expression of JAK1-dependent genes like GADD45α and TRIB3. Further, we do not
anticipate that inhibitors targeting JAK1 will have impacts on the homeostatic function of
the UPR. JAK1 inhibitors target the well-characterized kinase activity of JAK1. Here, we
demonstrate that this kinase activity is not necessary for ATF4-dependent gene
expression. Functional contributions of this STAT-independent gene expression in
physiological and disease conditions are not known. Previously, we showed that JAK1
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knockdown did not influence phosphorylation of eIF2α or expression of CHOP [13]. The
UPR is beneficial for adapting to acute, transient demands on the ER when there is large
demand for protein synthesis. However, chronic activation of the UPR, as demonstrated
in a variety of neurological diseases, is thought to be maladaptive. Overall, we have
described a novel JAK1-dependent signaling mechanism. Here, we found that, in
astrocytes, JAK1 can specifically bind ATF4 when it is expressed, JAK1 is expressed in
the nucleus, and that JAK1 is necessary for ATF4 to bind genetic promoters.
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Conclusions and Perspectives
Conclusions and Summary
Our work here has identified that JAK1, an immune-related tyrosine kinase, plays
a novel role in regulating responses to endoplasmic reticulum stress in the glial cell type
astrocytes. This work built upon previous reports from our lab that found PERK, a UPR
activator, drives inflammatory gene expression. This work sought to explore the possibility
of targeting ER stress to selectively attenuate inflammation associated with pathology
while retaining inflammatory responses that are restorative and promote homeostasis.
The Unfolded Protein Response has been well-characterized in peripheral cells
harboring high secretory capacity such as plasma cells and pancreatic β-cells. In the
CNS, the UPR has been studied in oligodendrocytes (due to their production of myelin)
and neurons. Astrocytes make up the largest proportion of cells in the CNS, therefore, we
believe that they are uniquely positioned to influence the trophic and inflammatory
environment. Astrocytes are physically proximal to blood vessels and neuronal synapses.
Although microglia are the bona fide immune cell of the brain and may produce higher
amounts of soluble inflammatory molecules on a per cell basis, astrocytes, due to their
large number, are likely to greatly contribute to the inflammatory milieu that influences
neurological diseases.
Using primary cultures of astrocytes, we found that astrocytes respond to ER
stress by producing the cytokine, IL-6. Here, we treated astrocytes with the
sarco/endoplasmic reticulum Ca²⁺ ATPase (SERCA) inhibitor, thapsigargin. Treatment
with this non-competitive SERCA inhibitor causes rapid depletion of ER calcium stores,
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inducing ER stress. As expected, induction of ER stress in astrocytes is associated with
enhanced gene expression of known ER stress induced genes CHOP, ATF4, and
GADD45α. Previous work in our lab demonstrated that PERK drives expression of those
genes, as well as expression of inflammatory mediators such as IL-6, CCL2, and CCL20.
IL-6, CCL2, and CCL20 production is driven by the JAK-STAT signaling pathway.
Therefore, we questioned if JAK-STAT signaling was required to drive ER stress-induced
IL-6 production. We knocked down JAK1 and JAK2 because these are the JAKs that are
most appreciably expressed in astrocytes. JAK3 and Tyk2 expression is restricted to cells
of the hematopoietic lineage. We used siRNA to knockdown JAK1 and JAK2 in primary
astrocytes and treated these astrocytes with thapsigargin to induce ER stress. We found
that JAK1 knockdown substantially ablated ER stress-induced IL-6 production. Further,
this is an effect that is specific to JAK1. JAK2 knockdown had no impact on ER stressinduced expression of IL-6. We treated astrocytes with thapsigargin. The astrocytes
responded with expression of ATF4 and CHOP, and eIF2α was phosphorylated. JAK1
knockdown had no impact on these expression levels indicating that canonical ER-stress
induced signaling molecules are not JAK1 dependent. Therefore, we hypothesized that
JAK1 uniquely drives transcriptional adaptation to ER stress in astrocytes.
To test this, we used RNAseq to understand the global impact that JAK1 has on
the ER stress induced transcriptome. We once again knocked down JAK1 and treated
with thapsigargin. Then, we isolated RNA and performed RNAseq. We determined all the
genes that are ER stress induced in astrocytes by performing EDGE analysis on the
RNAseq data [1]. We focused on genes that were at least 1.5-fold upregulated in
comparison to the untreated samples. Further, we ensured that there was not significant
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variation between technical replicates. After this analysis, we found a markedly large
number of genes are JAK1 dependent in response to ER stress. We identified over 400
genes to be significantly upregulated in astrocytes in response to ER stress, and 51 of
these genes were JAK1 dependent, suggesting that JAK1 plays a large role in controlling
the transcriptional adaptation to ER stress. Further, 15 of the top 50 (30%) ER stress
induced genes are JAK1-dependent, suggesting a vital role for JAK1 in response to
cellular stress.
We performed gene ontology to understand the biological functions of the JAK1dependent ER-stress induced genes. Many of the genes controlled by JAK1 in response
to ER stress had not been previously associated with canonical cytokine induced JAKSTAT signaling. To test this, we also performed RNAseq on primary astrocytes with or
without JAK1 knockdown and treated with the IL-6 family cytokine Oncostatin M (OSM).
As anticipated, most of the OSM induced genes were also JAK1 dependent. However,
the genes that were dependent on JAK1 in response to OSM were a distinct subset of
genes than those that were JAK1 dependent in response to thapsigargin. This suggests
that JAK1 controls a different subset of gene expression in response to different stimuli
(cell stress vs. cytokine stimulation).
To understand how this occurs, we hypothesized that JAK1 may be able to
coordinate gene expression in response to cell stress using additional molecules that are
not typically expressed under non-stress conditions. For example, since genes that are
JAK1-dependent in response to ER stress are different genes than those that are JAK1dependent in response to OSM, we hypothesized that other transcription factors may be
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utilized by JAK1 in addition to STATs. Further, this hypothesis was strengthened because
many of the ER stress induced JAK1 dependent genes did not have predicted STAT
binding motifs in their promoter regions. We examined the genes that are JAK1
dependent in response to ER stress and determined that many of these genes have been
reported in the literature to express ATF4, a transcription factor that is induced upon active
PERK signaling and expressed in response to thapsigargin treatment in astrocytes. We
chose to evaluate the PERK-dependent transcription factor ATF4 because it is lowly
expressed under basal conditions. ATF4 is only expressed under conditions of
phosphorylated eIF2α. eIF2α can be phosphorylated by PERK, under conditions of ER
stress, by GCNI, under conditions of amino acid deprivation, PRK, during viral infection,
or by HRI, under conditions where heme is limited. We hypothesized that, because ATF4
is selectively expressed under these conditions, this would provide JAK1 with an
opportunity to utilize ATF4 during conditions of ER stress. We found that many of the
JAK1-dependent genes are also dependent on ATF4. This included GADD45α and
TRIB3. We further evaluated genes that are classic inflammatory genes as well as genes
that have been associated with ER stress, but not JAK-STAT signaling. The candidate
genes we selected for further molecular analysis were IL-6 and CCL2 (inflammatory
genes) and GADD45α and TRIB3 (ER stress-related genes). Here, we confirmed IL-6,
CCL2, GADD45α, and TRIB3 are all JAK1-dependent in astrocytes treated with
thapsigargin. Further, the induction of IL-6 and CCL2 expression in response to ER stress
could be abrogated using the JAK1/2 inhibitor AZD1480, as expected. However,
GADD45α and TRIB3 were insensitive to this inhibition. This indicates that JAK1/ATF4
dependent genes may not rely on the characterized JAK1 kinase activity.
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To determine if JAK1 has a direct impact on ATF4 signaling, we tested if JAK1
knockdown reduces overall ATF4 expression in response to ER stress. JAK1 does not
regulate ATF4 expression. Next, we hypothesized that there may be a protein protein
interaction between JAK1 and ATF4. We demonstrated that ATF4 and JAK1
coimmunoprecipitate, suggesting there is a physical interaction between these proteins.
Further, we have seen that ATF4 is expressed specifically in the nucleus, leading us to
hypothesize that JAK1 also can be expressed in the nucleus in astrocytes under
conditions of endoplasmic reticulum stress.
We next hypothesized that the JAK1 and ATF4 interaction may influence the ability
of ATF4 to bind promoter regions and drive gene expression. To test this, we used ChIPqPCR and ChIP-seq immunoprecipitating for ATF4. First, we pulled down ATF4-bound
DNA sequences and ChIP-seq was used to expand these studies as an unbiased,
genome-wide fashion. We confirmed that ChIP-seq was successful by identifying the
known ATF4 binding motif in our sequences. Further, preliminary analysis suggests that
JAK1 is required, globally, for ATF4-promoter interactions. This suggests a unique role
for JAK1 in regulating transcription factor-DNA binding. To empirically confirm these
findings, we performed ChIP-RT-qPCR targeting predicted ATF4-binding regions in the
promoter of TRIB3. Here, we demonstrated that JAK1 is necessary for ATF4 to bind the
TRIB3 promoter.
This work has established JAK1 as a major regulator of ER-stress induced gene
expression in astrocytes. JAK1 has canonically been studied downstream of cytokine
receptors. Here, we show that endoplasmic reticulum stress can directly activate JAK1100

dependent signaling. To our knowledge, this work is the first to demonstrate noncanonical
JAK1 signaling in the CNS. Further, we have identified that JAK1 regulates global
promoter binding of the transcription factor ATF4 and is expressed in the nucleus.
Additionally, JAK1 controls transcription of different genes dependent on the stimulus that
activates JAK1. Therefore, we hypothesized that JAK1 utilizes alternative transcription
factors in addition to STATs. We found that JAK1 is necessary for ATF4 to bind promoter
regions in DNA, suggesting a significant impact on ER stress-induced transcription.

Discussion and Future Directions
Canonical and Noncanonical JAK1 signaling
We define canonical JAK1-dependent signaling as the activation of JAK1 upon
receptor ligation that creates a conformational change to increase JAK1’s tyrosine kinase
activity that facilitates recruitment of STATs to be phosphorylated by JAKs and activated
to drive gene expression. Our work has defined a noncanonical role for JAK1 signaling in
response to cell stress. Here, JAK1 can be activated by ER stress in a PERK-dependent
fashion. Further, JAK1 can cooperatively regulate expression via a novel mechanism
dependent on ATF4. Excitingly, we also identified JAK1 in the cytosol and nucleus,
challenging other reports that state JAK1 is constitutively associated with plasma
membrane-spanning receptors.
Our finding that 10% of the genes upregulated by ER stress are JAK1-dependent
leads to additional research questions. For example, two genes induced by JAK1 that we
did not focus on are NUAK1 and NUAK2 which are AMPK-related kinases that have been
implicated in neurological processes. NUAK1 and NUAK2 both contribute to neural tube
formation in development [2]. NUAK2 reportedly plays a role in neurodevelopment [3] and
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some types of cancer [4]. NUAK1 and NUAK2 are homologous [5], and NUAK1 has been
reported to play a role in neurodegeneration. In post-mortem brain tissue of AD and
progressive supranuclear palsy cases, there was an increased association of NUAK1 with
tau protein in comparison to age-matched controls. The same study found that NUAK1
phosphorylates tau, providing a mechanism for the link between NUAK1 activity and tau

Figure 4.1 JAK1 regulates basal and inflammation-induced C3.
A) Primary astrocytes were transfected with control or JAK1 siRNA and treated
with thapsigargin for 4 h. RNA was isolated and RNAseq was performed. B)
Primary astrocytes were treated with thapsigargin (1 µM) or tunicamycin (5 µM)
for 24 h. Protein lysates were collected and immunoblotted for C3 and ATF4 to
confirm ER stress induction. C) Primary astrocytes were transfected with siRNA
as in (A) and treated with neurotoxic oligomers (500 pg/ml) for 24 h. RNA was
isolated for qPCR. N = 3. D) Astrocytes were transfected with siRNA as in (A)
and treated with the TNF-α (5 ng/ml), OSM (2.5 ng/ml) or IL-1β (500 pg/ml) for
24 h. Protein lysates were collected for immunoblotting.
accumulation. Finally, this study crossed heterozygous NUAK1 knockout mice with the
P301S model of tauopathy. Partial loss of NUAK1 rescued some of the pathologies seen
in the P301S model including reduced hyperphosphorylated tau and fewer neurofibrillary
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tangles [6]. Therefore, this provides a hypothetical mechanism that could link
endoplasmic reticulum stress-mediated activation of JAK1 to hyperphosphorylation of tau
and subsequent tauopathy-associated neurodegeneration [2].
Another gene we identified in our RNAseq data as a JAK1-target gene is the
complement component C3. C3 has recently gained much attention as a marker of
reactive astrogliosis. C3-expressing astrocytes are implicated in a variety of neurological
and neurodegenerative diseases including PD, AD, MS, and stroke [7]. It is thought that
C3 expressing astrocytes aberrantly prune synapses, leading to neurodegeneration [712]. Thapsigargin does not appreciably induce C3 expression at the RNA level, but JAK1
siRNA abrogates basal C3 expression (Figure 4.1A). However, thapsigargin and
tunicamycin induce C3 protein expression (Figure 4.1B). Further, we found that
neurotoxic oligomers can induce C3 expression in a JAK1-dependent manner (Figure
4.1C). Proinflammatory cytokines also induce protein levels of C3, and this can be
reduced by siRNA-mediated JAK1 knockdown (Figure 4.1D). Although these findings are
outside the scope of the current project, this provides evidence that targeting JAK1 could
rescue the astrocyte-mediated synaptic loss and dysfunction in neurodegenerative
diseases.
Additionally, using RNAseq data generated in our lab and published elsewhere,
we found that JAK1 and ATF4 in astrocytes regulate genes related to histone 1. This
included genes such as Hist1h1d, Hist1h1c, and Hist1h1b [13]. Currently, there is little
known about the regulation of histone 1 related genes in astrocytes, and functional
consequences are yet to be explored. However, this information taken together with the
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previous reports that JAK1 and JAK2 can influence epigenetic modifications and
phosphorylate histones, we hypothesize that, in astrocytes, JAK1 may contribute to
epigenetic regulation.
Although these studies are outside of the scope of this project, this could be a
future direction of this project to expand on the mechanistic insights of JAK-dependent
signaling. Histone 1 molecules make up the linker portion of chromatin structure and
control DNA entry and exit sites. Interestingly, H1 protein knockouts in various model
organisms are viable and show that H1 does not act as a general suppressor of
transcription but impacts regulation of specific genes [14-17]. For example, knockdown
of H1-related genes has been demonstrated to upregulate expression of interferonstimulated genes (ISG) and induce interferon – β to limit viral replication [18]. Therefore,
although empirical evidence is needed, we suggest that JAK1 may promote basal
expression of ISGs via maintaining histone 1 gene expression. Further, overexpression
of Hist1h1c has been shown to induce autophagy in retinal ganglion cells [19]. Here,
Hist1h1c promotes cell death. It is possible that Hist1h1c could also mediate the JAK1dependent ER stress-induced transcriptional response. In addition to controlling histonerelated genes, our findings that JAK1 can be expressed in the nucleus support other
reports that suggest JAK1 regulates histones post-translationally at the epigenetic level.
The first discovery that JAKs may be able to function in the nucleus was the finding
that JAKs are associated with cytokine receptors. Some cytokine receptors that are
known to be associated with JAK-STAT signaling have been demonstrated to translocate
to the nucleus. Some of these cytokine receptors include growth hormone [20, 21], insulin
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[22-24], and the type I angiotensin receptor [25, 26]. Therefore, these reports suggest
that JAK1 could translocate to the nucleus with associated cytokine receptors. These
findings and others challenge reports that JAK1 is constitutively expressed near the
plasma membrane, including a 2004 study that demonstrated that the subcellular
localization of JAK1 is restricted to the plasma membrane. However, this was
demonstrated in HepG2, HeLa, A375, HUVEC, U4C, 2C4 cell lines [27], not primary cells.
JAKs have been reported to function non-canonically in the nucleus. However, we
are the first to report that this occurs in brain cells. In 2009, Dawson et. al found that JAK2
is present in the nucleus and can utilize its tyrosine kinase activity to phosphorylate
histones

and

modulate

heterochromatin.

Here,

JAK2

was

visualized

using

immunofluorescence in the hematopoietic cell lines HEL, UKE1, and K562 cell lines [28].
Additionally, cellular fractionation confirmed these results, demonstrating for the first time
that JAKs have roles in the nucleus. Previously, JAKs were thought be constitutively in
the cytosol to initiate STAT translocation to the nucleus. Here, in the nucleus, JAK2
tyrosine phosphorylated histone 3 at tyrosine 41 (H3Y41). This phosphorylation was
demonstrated to be required for the protein HP1α to bind histone 3 and regulate
expression of the gene LIM domain only 2 (also known as rhombotin-like 1) (lmo2). ChIPseq analysis revealed that lmo2 is required for yolk sac production of erythrocytes and is
considered an acute T-lymphoblastic leukemia-related oncogene. This provides a model
for JAK proteins to have a role in epigenetic regulation [28].
More recently, a similar phenomenon was demonstrated with JAK1. JAK1, in B
cell lymphoma cells, was found to be imported to the nucleus. Here, the authors identified
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a classical nuclear localization sequence (NLS) in JAK1. The NLS of JAK1 is a cluster of
basic amino acids located at amino acids 342 – 345. In HBL1 and OCI-Ly1 cell lines that
represent a type of B cell lymphoma (activated B cell diffuse large B cell lymphomas
(ABC-DLBCL)), JAK1 was found in the nucleus regardless of activation status of JAK1 by
cytokine receptor ligation using constitutively active mutants of JAK1 often associated
with ABC-DLBCL.
We demonstrated, in astrocytes, that JAK1 is in the nucleus and that JAK1
physically interacts with ATF4, which is also expressed in the nucleus. Further, we have
demonstrated that JAK1 influences an entirely distinct subset of gene expression in
astrocytes in response to ER stress. ATF4 regulated genes have bene linked to ER stress
induced cell death and apoptosis. For example, the pseudokinase TRIB3 that we have
identified to be both JAK1 and ATF4-dependent in astrocytes was first described in
Drosophila and has been reported to modulate glucose signaling by binding and inhibiting
protein kinase B (Akt) [29]. This results in a reduction in insulin-dependent
phosphorylation of GSK-3β [29]. This phosphorylation is important to inhibit
glycogenolysis. Therefore, these findings link ATF4-dependent expression of TRIB3 to
glucose output from the liver under fasting conditions [29]. Additionally, in cell lines
derived from hepatocarcinoma, TRIB3 inhibits Akt and mTORC1 and this was shown to
promote both autophagy and apoptosis, corroborating the previous findings. Further, in
aged rats, TRIB3 expression is increased in the liver. Here, this is associated with insulin
resistance [30]. Taken together, this suggests that, in response to ER stress, JAK1 could
drive inhibition of Akt in astrocytes in a TRB3-dependent mechanism.
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Figure 4.2 Development of BioID - a potential future direction to identify novel
JAK1-interacting molecules.
Primary astrocytes were transfected with a DNA construct encoding the promiscuous
biotin ligase, BirA or a BirA-JAK1 fusion protein. 100 µM of biotin was added to the
media 24 h after transfection. Protein lysates were collected 48 h post-transfection
and immunoprecipitated with streptavidin beads. These data demonstrate, as a proof
of concept, that the JAK1-BirA construct can be utilized to immunoprecipitate novel
JAK1-interacting proteins.
Mechanistic studies utilizing HEK293T cells showed that TRIB3 can interact with
SMAD3, an important downstream signaling molecule of the TGFβR1. This interaction
retains SMAD3 in the nucleus. The same study used trans-well migration assay to
demonstrate that HepG2 (representing carcinoma) cells with stable TRIB3 knockdown
failed to migrate to the same extent as control cells, indicating that TRIB3 may play a role
in tumor cell migration [31]. This still needs to be confirmed in vivo. However, in support
of these findings, the drug ABTL0812 that binds and activates transcriptional activity of
PPARα and PPARγ has been demonstrated to activate TRIB3 and promote cytotoxic
autophagy in cancer cells [29, 32, 33]. ABTL0812 has begun clinical testing and Phase I
study results show that it is well-tolerated in patients and will continue to Phase II testing
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[34]. Our findings suggest that JAK1 could similarly influence cancer cell migration
through regulation of ATF4 and subsequently, TRIB3.
Therefore, we believe our finding that JAK1 and ATF4 cooperatively regulate
TRIB3 expression in astrocytes via previously unknown mechanisms may promote
crosstalk with additional signaling pathways. For example, our work implies that ER stress
may, in a JAK1 and ATF4 dependent mechanism, inhibit AKT phosphorylation. However,
our work suggests that current therapeutics that target JAK1 would not impact TRIB3dependent consequences because JAK1-dependent expression of TRIB3 does not
require the phosphorylation of STATs.
Additional evidence that JAK1 signaling and metabolism could be linked is that
AMPK, a central regulator of metabolic signaling, can phosphorylate JAK1 and inhibit
JAK-STAT induced inflammation. This suggests that low nutrient status can be linked to
inflammatory activation of cells. For example, activating AMPK resulted in lower levels of
JAK1-mediated IL-6 production [35]. Although these links have not been fully investigated
in the CNS, and little is known about the immunometabolism of astrocytes, this is likely
an important study. The brain utilizes the majority of the body’s glucose, and astrocytes
play a vital role in nutrient processing for the CNS. Our work raises the possibility that,
under conditions of low nutrients, AMPK could inhibit JAK1-dependent production of
cytokines through traditional mechanisms. However, under these conditions, ATF4dependent genes may still be transcribed downstream of JAK1. For example, under
conditions of phosphorylated AMPK, JAK1-driven expression of TRB3 may inhibit
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glycogenolysis in astrocytes or impact other metabolic processes [36]. This suggests that
our findings, in addition to ER stress, may have broader applications in metabolic stress.
Our work has mechanistically linked the Unfolded Protein Response in astrocytes
to immunological signaling cascades. We have identified that JAK1 can utilize ATF4 to
regulate gene expression, however, there are many proteins that bind or interact with
JAK1 that could facilitate noncanonical signaling in addition to ATF4. One additional
approach that could address this possibility is using a proximity biotinylation approach to
identify novel proteins that interact with JAK1. Our lab has begun to optimize the BioID
approach, a type of proximity biotinylation technique (45). We have generated a JAK1
construct fused to a promiscuous biotin ligase, allowing biotinylation of interacting and
proximal proteins to JAK1 in experimental conditions (Figure 4.2). Biotinylation of JAK1
binding partners allows for streptavidin-dependent isolation and identification using mass
spectrometry.
We plan to strengthen the findings that JAK1 is in the nucleus and can bind ATF4
to modulate ATF4-promoter interactions. We will perform RNAseq on primary astrocytes
with or without ATF4 siRNA-mediated knockdown with thapsigargin treatment. We predict
that the thapsigargin induced genes that are JAK1 dependent, but insensitive to inhibition
by AZD1480 will have significant overlap with thapsigargin induced ATF4-dependent
gene expression. We have found this to be true with genes like GADD45α and TRIB3 and
anticipate that more genes will fall into this category.
To test the hypothesis that ATF4 sequesters JAK1 in response to ER stress, we
will knockdown ATF4 in primary astrocytes, treat with thapsigargin for 4 hours, and collect
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cellular fractions of whole cell lysate, cytoplasm, and nucleus. Like we have demonstrated
previously, we expect that JAK1 will be present primarily in the whole cell lysate and
enriched in the nucleus under ER stress. If ATF4 is required for this process, we expect
that in an ATF4 siRNA thapsigargin treated condition, there will be a loss of JAK1
accumulation in the nucleus in comparison to nontargeting control siRNA. If there is no
difference between nuclear JAK1 in the control siRNA and ATF4 siRNA thapsigargin
treated groups, the translocation of JAK1 to the nucleus could be dependent on additional
unknown factors.
The in vivo role of JAK1 in astrocytes
To understand the overall contribution of JAK1 signaling in astrocytes to
neuroinflammatory disease, we sought out to generate conditional astrocyte-specific
JAK1 knockouts in mouse models. JAK1 controls the signaling activity of many cytokines
including the IL-6 family, interferons, and the IL-10 family [37]. Many of these cytokines
are well-established to play roles in neurological diseases [38]. JAK1, JAK2, and STAT3
are the most highly expressed JAKs and STATs, respectively, in astrocytes. Both JAK1
and JAK2 can phosphorylate STAT3 to drive gene expression. Additionally, JAK
inhibitors, such as the JAK1/2 kinase inhibitor AZD1480, have been shown to ameliorate
disease progression in EAE and this is associated with lower numbers of infiltrating Th1
and Th17 cells, but the cell specific contributions are unknown [39, 40]. JAK1 knockout
mice are perinatal lethal. JAK1 knockout mice are born, but in fewer numbers and fail to
nurse so understanding the role of JAK1 in vivo has been limited [41]. Recently, a JAK1
floxed animal was generated by the group of Dr. Ross Levine. We obtained these mice
and crossed the JAK1fl/fl animals to the astrocyte specific GFAP-Cre (line 77.6) [42].
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However, no viable pups were generated from the GFAP-Cre JAK1fl/fl mice. Therefore,
we assume that astrocyte specific JAK1 knockout results in deleterious developmental
impacts. This is in line with previous literature demonstrating that global JAK1 deletion in
mice is perinatal lethal and that STAT3 is required for astrocyte development [41, 43].
An alternative approach that we have developed to understand the cell-specific
role of JAK1 in vivo is using a newly available tamoxifen inducible astrocyte specific cre
line (ALDH1L1 CreERT2). We plan to use this line to temporally control when JAK1 is
knocked out – for example, after the mice have reached adulthood. To test the in vivo
response

of

astrocyte

selective

JAK1

deletion,

experimental

autoimmune

encephalomyelitis (EAE) could be used to model neuroinflammatory disease. Although
these studies are outside of the scope of this current project, the generation of these
animal lines opens a multitude of future investigations evaluating the in vivo role of JAK1
signaling. Future studies will involve inducing EAE by immunizing mice (12 – 18 weeks
old) with an emulsion of CNS-specific protein, myelin oligodendrocyte glycoprotein
(MOG), and Complete Freund’s Adjuvant. This model will be used because it is
accompanied by excessive neuroinflammation, including upregulated cytokines and
chemokines, many of which are known to be JAK1-dependent. EAE is a model of MS,
but also will allow evaluation of astrocyte derived JAK1 signaling in both
neuroinflammatory and neurodegenerative phases of disease. Here, we will induce EAE
in control (JAK1fl/fl Cre negative) animals and JAK1Astro-KO animals. We will monitor
disease state, characterized by ascending paralysis, over a period of 45 days. We will
record mean onset day of disease, percent incidence, and mean peak score of disease.
We anticipate that JAK1Astro-KO mice will have later disease onset, lower percent
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incidence, and a lower mean peak disease score. At pre-onset (~day 8), onset (~day 10),
peak (~day 14), and chronic (~day 21), we will collect cerebellum and spinal cord tissues,
isolate RNA, and protein to evaluate inflammatory and ER stress markers via RT-qPCR.
Proinflammatory cytokine expression will be measured for the following cytokines: IL-6,
CCL2, CCL20, TNF-α, IFN-γ, IL-17, and IL-1β. We will also analyze activation
(phosphorylation) of STAT3 via western blotting. Infiltrating lymphocytes and monocytes
are key drives of neuroinflammation and neural injury in EAE and are recruited, in part,
by astrocyte-derived chemokines [44]. Therefore, flow cytometry will be used to analyze
infiltrating inflammatory cell populations including TH1 cells, TH17 cells, and macrophages
in control and JAK1Astro-KO tissue (cerebellum and spinal cord). We anticipate that JAK1
will appreciably lower the overall inflammatory profile in the brains and spinal cord in mice
afflicted with EAE. This will show that astrocytes play a central role in directing
neuroinflammation. However, because JAK1 also is important in signaling for the IL-10
family of cytokines, it is possible that astrocyte-specific knockdown will worsen EAE. This
may be because the IL-10 receptor will be unable to initiate expression of
immunomodulatory genes to quell the neuroinflammation. This would also be interesting,
because this would demonstrate an important cell-autonomous immunomodulatory role
for astrocytes in the context of EAE. We have generated the first inducible, CNS-specific
JAK1 knockouts. Therefore, there is a variety of neurological disease models, in addition
to EAE, in which astrocyte dependent JAK1 signaling mechanisms can now be studied.
We have generated this mouse line and mice are viable and show no overt phenotype
following tamoxifen injections.
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Figure 4.3 JAK1 global inducible in vivo knockouts.
JAK1 is knocked out in peripheral and central tissues in vivo using the inducible CAGGCreTM mice crossed to JAK1fl/fl mice. A) Represents the overall experimental schema.
Mice were injected with 75 mg/kg of tamoxifen suspended in corn oil intraperitoneally
(i.p.) for 7 consecutive days. After a 10-day washout period, mice were injected with 2
mg/ml of tunicamycin i.p. Tissues were harvested 12 or 24 hours later, and protein and
RNA were isolated. Protein lysates were evaluated by immunoblotting and RNA was
used for RT-qPCR.
In parallel to developing the ALDH1L1 Cre JAK1fl/fl line, we have crossed JAK1
floxed [45] to a global inducible Cre line (CAGG-CreERTM), isolated primary astrocytes,
and confirmed that we can successfully knockout JAK1 (JAK1cKO) as shown by
immunoblotting. We also showed by qPCR that Cre positive, JAK1fl/fl animals have
reduced cytokine-induced gene expression. Here, JAK1 can be conditionally deleted in
all cells. Isolating specific cell types will also allow us to knockout JAK1 ex vivo to
understand mechanisms of JAK1 signaling in a variety of cell types of interest. We have
established a role for JAK1/ATF4 dependent gene expression in astrocytes in response
to ER stress. Using these models, we will be able to translate this to various non-CNS
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cell types as well that are associated with ER stress including β cells, plasma cells,
macrophages, and T cells. This will be a powerful tool to analyze JAK1 signaling in
primary cells.
We have also tested this system in vivo. As described in Figure 4.3A, CAGG-Cre
negative or positive JAK1fl/fl mice were injected with tamoxifen to delete JAK1. In the liver,
JAK1 was effectively deleted (Figure 4.3B). To replicate our in vitro findings in vivo,we
also treated mice with tunicamycin for 12 or 24 h. Here, we found that tunicamycin induces
expressoin of IL-6 and TRIB3 in the liver (Figure 4.3C). TRIB3 is JAK1-dependent in the
liver in vivo (Figure 4.3C). In the brain, ER stress induces both IL-6 and TRIB3 and both
of these genes are JAK1-dependent in vivo, confirming our in vitro studies. Overall, this
suggests that the JAK1fl/fl animal model will be an effective tool in studying JAK1 in vitro.
This will also allow us to expand upon mechanistic understanding of JAK1 in
astrocytes and a variety of other cell types. For example, in astrocytes, expressing kinase
dead mutants of JAK1 is difficult because JAK1 is endogenously expressed. However,
this experiment will be extremely important to demonstrate that JAK1 can initiate gene
expression without using its characterized kinase activity to phosphorylate STAT
transcription factors, initiating STAT-dependent expression. Therefore, we will utilize
CAGG-Cre positive, JAK1fl/fl astrocytes to express wild type and kinase dead mutants of
JAK1. Subsequently, we will treat these astrocytes with thapsigargin to induce ER stress.
We anticipate that genes such as IL-6 will be induced upon thapsigargin treatment. This
induction will be ablated when JAK1 is knocked out but rescued when wild type JAK1 is
expressed. However, we hypothesize that rescuing expression with the JAK1 kinase dead
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mutant will fail to rescue IL-6 expression because IL-6 is dependent on JAK1-dependent
phosphorylation of STATs. However, we hypothesize that GADD45α and TRIB3 will be

Figure 4.4 Summary of JAK1-dependent signaling in response to ER stress.
induced upon thapsigargin stimulation and their expression will be similar in both the wild
type and kinase dead expression mutants. This experiment will provide empirical
evidence that the JAK1 and ATF4-dependent genes are not regulated by JAK1 kinase
activity.
Overall, our work here has established JAK1 as a central molecular regulator of
cellular stress in astrocytes. We are the first to identify novel mechanisms for JAK1
involving additional transcription factors (ATF4). This opens the possibility that additional
transcription factors may also control JAK1-directed gene expression in various states of
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cell stress. Our work has provided important insight to the role of the UPR signaling in
astrocytes. This is summarized in Figure 4.4. Although our work does not provide a
causal link to neurotoxicity, our work along with other work where ER stress has been
linked to neurotoxicity in models of neurodegeneration. However, neurotoxicity may be
the result of multiple unconfirmed mechanisms including: 1) initiation of apoptosis by the
UPR in neurons, 2) loss of supportive function in other CNS cells, such as glia, 3) UPR
signaling in glial cells have a gain of neurotoxic function, or 4) a combination of these
possibilities. Altogether, an accumulation of evidence suggests that the duration, cell type,
and inflammatory environment of the CNS dictates the consequences of active UPR
signaling. Therefore, careful studies examining cell-specific contributions of the UPR in
neurological disease models are necessary to form a complete picture.
In this work, we have provided evidence that activation of the UPR greatly alters
the transcriptome of murine astrocytes. We have provided molecular evidence that,
although the UPR attenuates translation, many secreted inflammatory molecules such as
IL-6 are still expressed under these conditions. We have demonstrated that JAK1 is a
major factor in driving adaptation to ER stress in astrocytes. JAK1 may have similar
mechanisms in response to other types of cell stress such as oxidative stress, nitric oxideinduced stress, or depletion of oxygen or resource availability. Now that JAK inhibitors
have been on the market for a few years, an interesting observational study to conduct,
clinically, would be to examine the neurological outcomes of patients taking JAK inhibitors
for other conditions, such as rheumatoid arthritis. This could provide proof of principle that
JAK inhibition has an impact on neurological outcomes in diseases such as ischemic
stroke, Alzheimer’s disease, among others.
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Here, we provide evidence that UPR signaling could substantially contribute to
astrocyte-driven neuronal disfunction. To gain complete understanding of the UPR in the
CNS, more advanced cell-specific studies must be completed. Gain and loss of function
studies in vivo in astrocyte conditional models are necessary and attainable future
directions for the field. Recent studies have established that substantial regional
heterogeneity of astrocytes exists [46]. Currently, astrocyte specific UPR signaling has
not been characterized or compared across regional locations of the CNS. The location
and composition of misfolded proteins is known to vary amongst each neurodegenerative
disease. Therefore, this prompts the possibility that UPR signaling in astrocytes can
greatly differ based on location, disease state or stage.
Overall, we have found that JAK1 plays a major role in the transcriptional
reprograming of astrocytes in response to endoplasmic reticulum stress. We have
demonstrated that endoplasmic reticulum stress drives JAK1-dependent gene
expression. Approximately 10% of the ER stress induced genes in astrocytes are JAK1dependent. This includes genes that are traditionally associated with JAK-STAT
signaling, such as IL-6. However, JAK1 uniquely regulates stress-induced genes such as
TRIB3 and GADD45α in an ATF4-dependent manner. Under conditions of ER stress,
JAK1 is expressed in the nucleus, and is required for ATF4 promoter interactions.
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Abstract
Astrocytes are glial cells that support neurological function in the Central Nervous
System (CNS), in part, by providing structural support for neuronal synapses and blood
vessels, participating in electrical and chemical transmission, and providing trophic
support via soluble factors. Dysregulation of astrocyte function contributes to neurological
decline in CNS diseases. Neurological diseases are highly heterogeneous but share
common features of cellular stress including the accumulation of misfolded proteins.
Endoplasmic reticulum (ER) stress has been reported in nearly all neurological and
neurodegenerative diseases. ER stress occurs when there is an accumulation of
misfolded proteins in the ER lumen and the protein folding demand of the ER is
overwhelmed. ER stress initiates the unfolded protein response (UPR) to restore
homeostasis by abating protein translation and, if the cell is irreparably damaged,
127

initiating apoptosis. Although protein aggregation and misfolding in neurological disease
has been well described, cell-specific contributions of ER stress and the UPR in
physiological and disease states are poorly understood. Recent work has revealed a role
for active UPR signaling that may drive astrocytes towards a maladaptive phenotype in
various model systems. In response to ER stress, astrocytes produce inflammatory
mediators, have reduced trophic support, and can transmit ER stress to other cells. This
review will discuss the current known contributions and consequences of activated UPR
signaling in astrocytes.

Keywords:
astrocytes, endoplasmic reticulum, cell signaling, protein folding, translation, glia
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Main Points:
•

Astrocytes experience endoplasmic reticulum (ER) stress during
neuroinflammatory and neurodegenerative diseases

•

ER stress activates the unfolded protein response (UPR) in astrocytes and
drives the production of inflammatory molecules including IL-6, CCL2,
CCL20, CCL3 CXCL1, CXCL10, Lcn2, VEGF, and C3

•

Astrocytes under ER stress can induce UPR and inflammatory signaling in
neighboring cells

•

Activated UPR in astrocytes may contribute to neurotoxicity and/or
reduced neuronal and synaptic support

Introduction
Endoplasmic Reticulum Stress and the Unfolded Protein Response

Secreted and membrane bound proteins are translated and processed in the
endoplasmic reticulum (ER). Within the ER, proteins mature by folding into the proper
tertiary and quaternary structure and acquire necessary post-translational modifications.
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The ER is also critical for membrane lipid production and for the regulation of intracellular
Ca2+ [47]. Often, proteins within the ER fail to fold into the correct form. Fortunately, the
cell has intrinsic quality control mechanisms that eliminate misfolded proteins, such as
chaperone-mediated folding [48] and ER associated degradation (ERAD) [49, 50].
However, when these control mechanisms are overwhelmed, misfolded proteins
accumulate in the ER lumen. The aberrant accumulation of misfolded proteins and
concomitant induction of ER stress has been observed in many diseases and cell types
[51, 52]. ER stress occurs when a cell can no longer keep up with the demand to fold
proteins due to the number of misfolded proteins in the ER lumen. ER stress initiates a
highly conserved adaptive mechanism called the unfolded protein response (UPR). The
intracellular signaling stimulated by ER stress is aimed at restoring homeostasis;
however, if the stress is not alleviated, prolonged ER stress can drive cell death and
inflammation which may contribute to pathology [52].
ER stress can occur transiently in physiological conditions when there is an
increased demand for protein secretion, or in pathogenic states where ER stress occurs
due to genetic mutations, oxidative stress, ischemia, or other maladaptive cellular states.
Physiological ER stress has been best characterized in cells harboring high secretory
capacities such as pancreatic β cells and antibody-producing B cells [53-59]. Although
UPR activation is necessary to maintain homeostasis and clearly plays a role in
homeostatic processes, tight regulation of the UPR is paramount for maintaining cellular
health. Persistent activation of the UPR is reported in multiple diseases, including
diabetes, cancer, and neurodegeneration [60-62].
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There are three known proteins which sense the accumulation of misfolded
proteins and transmit distinct signals to the cytosol and nucleus to modify transcriptional
and translational programs to cope with ER stress. These trans-ER membrane proteins
are inositol requiring enzyme 1 (IRE1), protein kinase R-like ER kinase (PERK) and
activating transcription factor (ATF) 6. These enzymes are maintained in their inactive
state through interaction with the ER-resident protein chaperone glucose regulated
protein (GRP) 78 (also known as binding immunoglobulin protein (BiP)) proteins [63].
GRP78 binds broadly to hydrophobic residues that are exposed by misfolded proteins
[64]. Excess misfolded proteins recruit GRP78 away from the luminal domains of PERK,
IRE1, and ATF6 allowing activation [65, 66]. PERK and IRE1 can also directly interact
with misfolded proteins which contributes to its activation via a ligand-receptor type
interaction [67-71]. Figure 5.1 provides an overview of the UPR signal transducing
molecules.
IRE1 is the most evolutionarily conserved UPR initiator and contains both kinase
and endoribonuclease domains. Following release of GRP78, IRE1 oligomerizes in the
ER membrane facilitating trans-autophosphorylation of IRE1 which increases RNase
activity [72-74]. IRE1 then splices the mRNA of x-box-binding protein (XBP1) to remove
a small stop codon-containing intron which allows translation of the functional
transcription factor leading to expression of genes encoding molecular chaperones and
ERAD. Further, the activation of IRE1 kinase can promote stress signaling pathways such
as c-Jun N-terminal kinase (JNK) and Nuclear Factor kappa-light-chain-enhancer of
activated B cells (NF-κB) [75, 76] [77]. Additionally, the RNase activity of IRE1 mediates
regulated IRE1-dependent decay (RIDD) in which a subset of ER-targeted mRNAs are
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degraded [78, 79]. Collectively, IRE1 drives XBP-1-dependent gene expression that
includes ER chaperones and, through RNA degradation, reduces nascent polypeptide
entry into the ER to reduce the folding demand [79, 80].
PERK is a trans-ER membrane serine/threonine kinase which is activated by
misfolded proteins in the ER lumen. Following release of GRP78, PERK dimerizes and
trans- and auto-phosphorylates to increase its kinase activity [63, 81]. PERK
phosphorylates the eukaryotic initiation factor (eIF) 2α which leads to binding and
inhibition of the guanine nucleotide exchange factor (GEF) eIF2B. This prevents formation
of the complex needed to load the 43S ribosome with methionine, thus preventing
translation initiation [82, 83]. Under these conditions, some proteins are selectively
translated. For example, activating transcription factor (ATF) 4 is translated when eIF2α
is phosphorylated. ATF4 translation can lead to expression of CHOP (encoded by the
gene ddit3). In many cases, CHOP acts as a proapoptotic factor. Overall, PERK activation
reduces the protein load on the ER, and if mechanisms fail to restore homeostasis, initiate
cell death.
ATF6 is a transmembrane glycoprotein that is a member of the basic leucinezipper proteins (bZIP) transcription factor family. Upon the accumulation of misfolded
proteins and disassociation of GRP78, ATF6 localizes to the golgi apparatus where is
cleaved by site-1 and site-2 proteases [84], revealing a nuclear localization sequence.
Subsequently, ATF6 translocates to the nucleus and binds promoter sequences to
increase gene expression of ER protein chaperones and UPR regulators to increase
folding capacity of the ER [85].
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Overall, IRE1, PERK, and ATF6 are activated in response to the accumulation of
misfolded proteins within the ER lumen to promote efficient protein folding through the
upregulation of protein chaperones and by reducing the folding burden on the ER by
eliminating influx of mRNA and polypeptides. If these mechanisms are insufficient,
persistent UPR activation will promote apoptosis to eliminate the irreparably damaged
cell.
Unfolded Protein Response and Astrocytes

The UPR is activated transiently to restore homeostasis, however, chronic UPR
activation has been implicated in Central Nervous System (CNS) diseases including, but

Figure 5.1 The canonical Unfolded Protein Response (UPR) is activated by 3
trans-ER membrane sensors: IRE1, PERK, and ATF6.
Figure was created in Biorender.
not limited to, Alzheimer’s disease (AD), Multiple Sclerosis (MS), traumatic brain injury
Figure was created in Biorender.
(TBI), stroke, prion disease, Parkinson’s disease (PD), and Huntington’s disease (HD)
[86-100]. Many of these CNS disorders include components of misfolded or aggregated
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proteins. However, the UPR has been primarily studied in neurons and oligodendrocytes
(recently reviewed in [101-103]).
Astrocytes comprise a large portion of the CNS and are vital for proper neuronal
survival and function [104, 105]. Historically, astrocytes were considered a homogenous
population that primarily played a role in structural support to the CNS, however, technical
advances and meticulous experimentation have shown that astrocytes are a
heterogeneous and dynamic population of CNS-resident cells, playing important roles in
both homeostasis and disease [106-108]. For example, astrocytes support synapse
formation and function through both physical interactions and secreted molecules [109].
Astrocytes play a role in synaptic pruning during development, which is essential for
proper neural development [12]. Astrocytes also support synaptic function by regulating
ion homeostasis (Ca2+, Cl-, K+), water transport, and neurotransmitter reuptake and
recycling [110, 111].
In addition to their supportive role, astrocytes respond to insult and injury, can
promote neurotoxicity, and direct CNS inflammation by promoting microglial activation
and leukocyte trafficking. Inflammation, particularly proinflammatory cytokines such as
interleukin (IL) - 6, IL-1, tumor necrosis factor (TNF) -α, and the complement system, play
an important role in neurological diseases and are associated with worsened neurological
outcomes [112-116]. Astrocytes are key directors of inflammation within the CNS. It is
well established that astrocytes undergo transcriptional and phenotypical changes in
response to injury, called astrogliosis [111]. During astrogliosis, astrocytes have
increased proliferative capacity, glial fibrillary acidic protein (GFAP) expression increases,
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signaling molecules and cytokines are upregulated, the extracellular matrix remodels, and
changes in ability of astrocytes to properly regulate synapses and the blood brain barrier
(BBB) occur. Reactive astrocytes can have differential roles depending on the injury or
disease. For example, reactive astrocytes worsen AD, but during ischemia or spinal cord
injury, reactive astrocytes promote overall neural recovery [117-125].
Perturbations in astrocyte function are now implicated in many neurological
diseases including PD, AD, ischemic stroke, epilepsy, and ALS ([111]. This highlights the
importance of astrocytes in maintaining and directing neurological function. However, the
mechanisms by which cellular stressors initiate astrocyte dysfunction that contributes to
disease are not well understood. Recently, single cell RNA sequencing (scRNAseq)
revealed that subpopulations of astrocytes that are expanded during Experimental
Autoimmune Encephalomyelitis (EAE) have increased UPR signaling, suggesting that the
UPR is associated with EAE [126]. Additionally, overexpression of spliced XBP1 in
astrocyte-like glial cells in C. elegans extends life span [127]. Astrocytes express all the
initiating sensors of the UPR (IRE1, PERK, and ATF6) and express the ER stress
sensitive molecule, old astrocyte specifically induced substance (OASIS). Further,
astrocytes are largely resistant to aberrant ER stress-induced cell death [128]. GRP78 is
important in protecting astrocytes as shown by overexpression in the in vitro stroke model
of oxygen glucose deprivation [129].
Astrocytes have been demonstrated to express many cytokines, chemokines, and
reactive species that contribute to the inflammatory environment of the CNS [130]. Table
1 describes molecules that have been demonstrated to be induced by ER stress in
135

astrocytes. Further, the UPR has been explicitly linked to initiating inflammation in other
cells types. For example, UPR activation augments inflammatory responses stimulated
by the bacterial cell wall component lipopolysaccharide (LPS) and can directly drive
activation of the acute phase response [131, 132]. Taken together, accumulating
evidence suggests that chronic ER stress and UPR signaling in astrocytes may play a
pathological role in neurological disease.

IRE1 in astrocytes
IRE1 signaling has been linked to cell death and inflammation in the CNS.
Evidence of active IRE1 signaling has been reported in post-mortem human tissue in
clinically confirmed cases of AD, HD, and glioma in addition to many mouse in vivo and
in vitro disease models. In an immortalized astrocytic cell line, SVGA, cells infected with
HIV-1 require IRE1 signaling to activate JNK and activator protein (AP) -1 to induce cell
death [133]. Further, nitric oxide (NO) has also been demonstrated to activate IRE1dependent signaling in human glioma cell lines. Treating human astrocytoma (CRT-MG)
cells with an NO donor and the ER stress inducer, thapsigargin, increased apoptosis that
coincided with IRE1 nuclease activity, IRE1/TRAF2 complex formation, and p-JNK1/2
levels, implying that treatment of NO subsequently activates the IRE1-α/TRAF2/JNK
pathway. IRE1 knockdown confirmed that intracellular NO affects IRE1-dependent
phosphorylation of CREB in human glioma cells [134]. Together, this suggests pathogenic
stimuli (viral infection and reactive nitrogen species) can activate the IRE1 arm of the
UPR and contribute to cell death in in vitro astrocytoma cell lines.
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In vivo evidence suggests that IRE1 signaling in astrocytes is associated with the
neurodegenerative diseases AD and MS. In brain tissue from AD patients,
phosphorylated IRE1 is increased and correlates with disease severity based on Braak
Staging, a pathology-based characterization of AD [90, 135, 136]. To investigate the role
of IRE1 in a mouse model of AD, IRE1 was deleted in the nervous system using Nestincre and crossed with the 5XFAD genetic model of AD. Genetic deletion of the RNase
domain of IRE1 significantly reduced amyloid deposition and astrocyte activation. Further,
deficiency of IRE1 signaling improved synaptic function and long-term potentiation,
suggesting restored memory and learning capacity of the mice. This led to the
amelioration of disease hallmarks including Aβ1-42 production, amyloid plaque deposition,
and cognitive deficits. Additionally, deletion of IRE1 reduced astrogliosis, based on GFAP
staining, in the 5XFAD hippocampus. In this case, attenuation of gliosis may be through
a direct effect on astrocytes or due to reduced overall disease burden [90]. Further AD
studies are needed to delineate the astrocyte-specific contributions of IRE1 signaling.
In a large pharmacogenetic screen to identify signaling pathways involved in
pathogenic neuroinflammation in MS, astrocytes were stimulated in vitro with TNF-α and
IL-1β, two cytokines known to be associated with the pathogenesis of EAE and MS. Here,
Wheeler et. al determined that IRE1 is phosphorylated and XBP1 was spliced, suggesting
activation of IRE1 signaling during astrocyte-mediated neuroinflammation. To confirm this
in vivo, this study used cell-specific lentiviral delivery of short hairpin (sh) – RNA targeting
the gene that encodes for IRE1 (ern1) to knockdown expression in astrocytes during
active EAE, which reduced disease severity. These studies demonstrated that abrogating
expression of IRE1 under control of the astrocyte selective GFAP promoter ameliorated
137

EAE disease course and reduced inflammatory mediators produced by astrocytes [137].
This suggests that IRE1 signaling in astrocytes is pathogenic in the murine EAE model of
MS.
These studies, collectively, imply that IRE1 signaling in astrocytes can be activated
by various stimuli and that activated IRE1 can integrate with many signaling pathways
that promote inflammation or cell death.

PERK in astrocytes
Activated PERK signaling has been reported in a variety of neurological diseases
including AD, MS, prion disease, neurotropic viral infection, and ALS [88, 95, 138, 139].
Using immunocytochemistry to analyze brain tissue of human MS samples, the UPR
proteins GRP78, XBP-1, and CHOP were increased in acute MS lesions [140]. In models
of prion disease, neuronal cell lines were infected with PrP, the misfolded protein
associated with prion disease. Prion infected neurons were more susceptible to cell
death, and targeting PERK signaling in in vivo models of prion disease is protective [94,
95, 98]. Some reports show that prolonged expression of CHOP is pro-apoptotic, but this
has not directly been demonstrated in primary astrocytes or in vivo models [141, 142].
However, the Venezuelan Equine Encephalomyelitis Virus (VEEV) induces apoptosis of
the astrocyte-like glioblastoma cell line (U87Mg) through CHOP expression that is
activated by PERK [143]. PERK knockdown in primary astrocytes reduces viral load of
VEEV, but there is no difference in viral load between U87Mg cells with or without PERK
expression [144].
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Further, evidence of activated PERK signaling in astrocytes has been reported in
neuropathological studies of human AD and PD brains [88, 145]. Additional studies have
established that PERK is phosphorylated in glial cells in brains from tauopathy-associated
dementias [139]. In a 2014 study, Devi and Ohno examined the role of a hemizygous
PERK knockout crossed to the genetic AD model, 5XFAD. Genetic PERK ablation
reduces phosphorylated eIF2α and ATF4. PERK haploinsufficiency in 5XFAD mice
partially rescued memory loss in a behavioral fear conditioning model. These cognitive
improvements coincided with a reduction in amyloid-β plaque burden in hippocampal and
cortical regions of 5XFAD mice. Importantly, the maladaptive effects of PERK signaling
were specific to onset of AD; there were no measured cognitive changes in unaffected
PERK+/- mice compared to control animals [146].
In sporadic ALS and in the transgenic ALS mouse model that expresses mutant
superoxide dismutase (SOD)G93A, immunohistochemistry staining of spinal cords
demonstrated that many astrocytes, along with other cell types, expressed CHOP,
suggesting that PERK signaling is activated in astrocytes in ALS [138]. Another study
modeling ALS in mice demonstrated that astrocytes are activated, as quantified by GFAP
immunofluorescence staining. Here, mice expressing wild type human SOD, which has
been reported to spontaneously aggregate and model spontaneous ALS, were exposed
to the pharmacological inhibitor of N-linked glycosylation (tunicamycin) to induce UPR
activation, which was shown to increase SOD1 aggregation. Importantly, wild type
littermates did not have a significant increase in GFAP staining upon tunicamycin
treatment [147]. This suggests that SOD aggregation and UPR activation enhance GFAP
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expression, which is associated with a reactive astrocyte phenotype, in a murine ALS
model.
PERK is also active in models of acute brain injury. In the TBI model of controlled
closed cortical impact, PERK is phosphorylated and colocalizes with GFAP, a marker of
reactive astrocytes. In vitro analyses identified that the calcineurin isoform β (CNβ) can
interact with PERK to drive its oligomerization and downstream activation of the UPR,
independent of CNβ phosphatase activity. Here, the authors found that CNβ loss is
detrimental in TBI and photothrombotic stroke models. In stroke, this is associated with
reduced phosphorylation of eIF2α and increased GFAP expression. Additionally,
overexpression of CNβ attenuated astrocyte toxicity from oxidative and hypoxic insults
through a PERK dependent mechanism [100]. This suggests a potential role for PERK
signaling in promoting astrocyte survival after acute injury. These findings are consistent
with other reports using the blast injury model of TBI in which GFAP expression is induced
upon injury and is reduced when treated with the phosphatase inhibitor salubrinal to
maintain eIF2α phosphorylation [148]. Salubrinal reduced impulsive-like behavior induced
by repeated blast injury, suggesting that prolonging eIF2α phosphorylation in acute injury
models may be protective [148]. Similarly, p-eIF2α, GRP78, and CHOP expression is
increased post TBI and these markers of ER stress colocalize with GFAP-positive
astrocytes and multiple other cell types. Here, salubrinal improved motor function and
spatial defects as tested by the Morris Water Maze post-TBI [149]. Although these studies
did not directly define functional mechanisms in astrocytes, they provide evidence of
reactive astrocyte activation and ER stress during acute neuronal injury. Importantly,
while enhancing or maintaining eIF2α phosphorylation immediately after injury provides
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protection, reversing the p-eIF2α-mediated translational block using the eIF2B agonist
ISRIB during the chronic phase (4 weeks post injury) improves cognitive function [150].
These studies indicate that PERK signaling, and potentially other eIF2α kinases, have
differential effects during the acute and chronic phases following cerebral injury. The role
of PERK signaling in astrocytes in either phase is unknown and warrants additional
astrocyte-specific loss- or gain-of-function studies.
Additionally, Vanishing White Matter Disease (VWM) demonstrates the importance
of downstream PERK signaling in astrocytes. VWM is a leukoencephalopathy in which
dysfunctional astrocytes are thought to drive pathogenesis [151]. VWM is caused by an
autosomal recessive mutation in eIF2B, which reduce function and cause prolonged
suppression of protein translation in response to stimuli that promote eIF2α
phosphorylation [152, 153]. This highlights a role for phosphorylated eIF2α-driven
translational repression in preserving astrocyte homeostasis and directly links signaling
components downstream of PERK to neurological disease.
To date, multiple reports link UPR-dependent PERK signaling in astrocytes to
inflammatory gene expression and/or neurotoxicity [93, 128, 154, 155]. ER stressinducing pharmacological agents thapsigargin and tunicamycin promote phosphorylation
of eIF2α in primary murine astrocytes. [93, 154, 156, 157]. A 2014 study demonstrated
that gene expression of inflammatory markers (IL-6, CCL2), astrocyte markers (GFAP,
OASIS), and ER stress-related genes (GRP78, CHOP, PERK, ATF4) are upregulated
throughout the course of EAE in brain and spinal cord tissue. Downstream markers of
PERK activation such as phosphorylation of eIF2α and CHOP expression are exhibited
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in thapsigargin-treated astrocytes concomitantly with upregulation of IL-6, CCL2, and
CCL20. Additionally, ER stress augmented IL-6 expression induced by IL-6 or oncostatin
M (OSM) in a PERK-dependent fashion. This suggests that astrocytes may contribute to
the UPR and inflammatory response seen in CNS tissue during EAE. It is important to
note that these inflammatory proteins are induced at the protein level even under
conditions of phosphorylated eIF2α, which functions to attenuate translation,
demonstrating that these proteins are translated during UPR activation [128].
PERK is an important driver of inflammatory gene expression in astrocytes in
response to ER stress. A partial (heterozygous) or complete (homozygous) genetic loss
of PERK in primary astrocytes was associated with a lower astrocyte-driven expression
of as IL-6, CCL2, and CCL20 analyzed by qPCR or ELISA. Further, primary astrocytes
treated with thapsigargin and a PERK inhibitor, GSK2606414, reduced production of
cytokines and chemokines measured by ELISA. This demonstrates that PERK activation
contributes to both transcriptional and translational activation of inflammatory mediators
in astrocytes [154]. Therefore, unresolved UPR activation may contribute to prolonged,
aberrant inflammatory activation via PERK signaling that may contribute to the nonresolving nature of neurological diseases.
Cytokines such as IL-6, which is driven by PERK activation in astrocytes rely on
Janus Kinase (JAK) – Signal Transducer and Activator of Transcription (STAT) signaling
to exert their effects. JAK-STAT signaling has been directly linked to astrocyte-driven
pathology in neurodegeneration. STAT3 activation occurs in astrocytes in response to
acute injury and is required for astrocytes to form glial scars and take on a reactive
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astrocyte phenotype (astrogliosis) [158]. Astrocytes in models of AD, HD, and MS also
express higher levels of phosphorylated STAT3 [159]. Additionally, JAK inhibition
ameliorates disease progression in rodent models of PD and MS [40, 160].
PERK signaling activates downstream signaling in a JAK1 dependent mechanism,
and inhibiting JAK1 kinase activity reduced ER stress-induced inflammatory gene
expression. Importantly, JAK1 inhibition does not impact all ER stress-induced gene
expression. Further, it has been shown that PERK activates JAK1 to drive a subset of
gene expression that is distinct from those induced by the JAK/STAT activating cytokine
OSM [157]. This demonstrates that UPR signaling modulates inflammatory responses in
a manner distinct from traditional inflammatory signaling. Taken together, this evidence
suggests that PERK and JAK-STAT signaling in neurodegenerative disease models may
promote aberrant inflammation. Targeting PERK signaling in astrocytes may be a
mechanism to selectively attenuate immune responses in neurological diseases.
Targeting the UPR to selectively attenuate inflammation is supported by work in
other cell types. For example, UPR signaling in macrophages activates proinflammatory
cytokine signaling via the IRE1 pathway. Here, ER stress activates the nucleotide-binding
oligomerization domain-containing protein (NOD) 1/2 and sXBP1 in an IRE1 dependent
manner. Contrary to macrophages, PERK drives IL-6 expression in astrocytes. This
highlights that the UPR regulates inflammation using distinct mechanisms in different cell
types [161, 162]. ER stress-induced IL-6 production in astrocytes differs from
macrophages in that it requires PERK and JAK1 but is independent of IRE1 and nuclear
factor-κB (NF-κB) [128, 154]. Additionally, endothelial cells produce IL-6 in response to
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ER stress, but here, this IL-6 expression is dependent on both ATF4 and sXBP1 [163].
ER stress induced IL-6 expression in astrocytes does not rely on ATF4 signaling, as
demonstrated using siRNA-mediated knockdown of ATF4 in primary astrocyte cultures
[157]. This illustrates the need for more careful investigations regarding the nuances of
UPR signaling in various cell types. For example, the UPR in the CNS literature focuses
heavily on neurons and oligodendrocytes, however, these findings may not apply to
astrocytes. Although astrocytes induce IL-6 and other inflammatory molecules in a PERKdependent fashion, this is not the case for other IL-6 family members. Importantly, ciliary
neurotrophic factor (CNTF) is downregulated upon ER stress induction in cultured
astrocytes [13]. This suggests trophic support from astrocytes can be restricted by the
UPR. Indeed, it has been shown that ER stressed astrocytes lose trophic support for
neuronal synapse formation [93].
Collectively, multiple studies have demonstrated that PERK signaling promotes an
astrocyte-driven inflammatory response. Although inflammation provides a beneficial and
restorative role, chronic inflammation is thought to contribute to neurological disease.
PERK signaling in astrocytes may be a target to selectively attenuate damaging
inflammation while retaining beneficial inflammatory signaling in the CNS. Further studies
and conditional deletion of PERK and downstream signaling components in astrocytes
are needed to solidify the role in disease models.

ATF6 and OASIS in astrocytes
ATF6 and old astrocyte specifically induced substance (OASIS (CREB3L1)) are
bZIP transcription factors similarly activated in response to ER stress. OASIS is a
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molecule primarily expressed in astrocytes in the CNS. Upon activation, it is transported
to the golgi apparatus, is cleaved, and the N-terminal domain promotes expression of
ERAD-associated genes [164]. ATF6 is activated (cleaved) in embryonal astrocytes
during differentiation suggesting a role for ATF6 in astrocyte development [165]. OASIS
is also important for astrocyte differentiation. In mice lacking OASIS, astrocyte
development was impaired. OASIS was shown to bind the promoter of glial cells missing
transcription factor 1 (Gcm1) and promote Gcm1 expression. Gcm1 may regulate GFAP
promoter methylation allowing transcriptional activation. The reduced expression of
Gcm1 in OASIS-/- mice may, in part, underlie the reduced astrocyte differentiation [165].
To date, few studies have been performed examining the role of ATF6 in astrocytes during
disease states. In a murine model of ischemic stroke, middle cerebral artery occlusion
(MCAO), ATF6 knockout mice exhibited reduced infarct area as analyzed by the
metabolic stain triphenyl tetrazolium chloride (TTC). Concomitantly, ATF6α knockout
mice had reduced STAT3 activation and expression of GFAP in the ischemic area of the
brain 3 days post MCAO as measured by immunoblotting [166]. This study suggests that
ATF6 is protective during ischemia via an astrocyte-dependent mechanism.
OASIS activation has also been linked, in astrocytes, to AD disease mechanisms.
Apolipoprotein E (ApoE) is a protein involved in catabolizing triglycerides and the ApoE4
allele is strongly associated with the development of AD, although causal associations
between ApoE4 and AD are not fully known, reviewed in [167]. Primary astrocytes
expressing mutant APOE, to model human ApoE4, exhibit reduced ApoE expression and
increased UPR activation, including cleavage of OASIS and genes downstream of the
IRE1 and PERK pathways. This suggests that ApoE can induce cleavage of OASIS in
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astrocytes and activate the UPR in astrocytes and promote neuronal toxicity [168].
Collectively, there are limited studies on the role of ATF6 and OASIS, however, these
studies demonstrate that activation must be well-regulated for proper astrocyte function.

Non-cell autonomous effects of ER stressed astrocytes
In a 2017 study, Sprenkle et. al was the first to describe that astrocytes can
transmit ER stress to other cell types. A phenomenon that was previously described in
cancer cells and termed transmissible ER stress (TERS) [169]. This suggested that UPR
activation in astrocytes can induce UPR signaling in neighboring cells. In this study,
astrocyte conditioned media (ACM) collected from astrocytes treated with the ER stressinducing agent thapsigargin or tunicamycin was transferred to HT-22 hippocampal
neuronal cells. The cells that were exposed to thapsigargin treated ACM exhibited higher
gene expression and protein levels of GRP78, spliced XBP1, and CHOP, indicating that
astrocytes secrete a soluble factor that stimulates an ER stress response. Further, this
study showed that neurons experiencing ER stress also secrete a molecule that induces
ER stress in cultures of neurons, astrocytes, and microglia [156]. This study identified that
UPR activation can be transmitted between cells of the nervous system. These studies
are consistent with previous work that demonstrated that ER stress is also transmissible
between cancer or myocardial cells and macrophages, which also respond to ER stress
by producing inflammatory molecules, albeit these mechanisms are distinct from those
identified in astrocytes [13, 170, 171]. ER stressed astrocytes, through a PERKdependent process, also increase microglial expression of IL-1β and IL-6 [128].
Independently of PERK, ER stressed astrocytes reduce microglial expression of arginase,
CD206 and insulin like growth factor 1 [154]. Together, these data indicate that in
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response to ER stress, astrocytes can shift microglia to an inflammatory phenotype.
Additionally, Wheeler and colleagues demonstrated that XBP1 knockdown in astrocytes
decreases the number of monocytes that traffic to the CNS during EAE. Macrophages
that trafficked to the CNS during EAE in the GFAP-driven XBP1 knockdown had reduced
expression of inflammatory genes involved in IL-6 signaling, NF-κB signaling, and
chemokine signaling. Similarly, microglia in the astrocyte specific XBP1 knockdown had
reduced proinflammatory gene expression in comparison to EAE animals with XBP1
expression astrocytes [137].
Astrocyte conditioned media from healthy astrocytes is known to support
synaptogenesis [172-174]. To determine if UPR activation impacts the ability of astrocytes
to support synapses, Mallucci and colleagues collected astrocyte conditioned media
(ACM) from thapsigargin-treated astrocytes. By immunostaining pre and post synaptic
terminals, ACM from UPR activated astrocytes was shown to reduce synaptogenesis.
Further, inhibiting PERK pharmacologically restored the ability of ACM to promote
synapse formation, suggesting that UPR activation via PERK inhibits astrocyte-mediated
neurotrophic functions. Further, this study tested if targeting PERK-eIF2α signaling in vivo
could be neuroprotective. Using mice that over express prion protein (PrP) and succumb
to prion infection. Astrocyte specific lentiviral overexpression of GADD34, an eIF2αspecific phosphatase, was markedly protective in prion-infected mice. GADD34
overexpression (to reduce PERK signaling) in astrocytes prevented neurodegeneration
in the hippocampus, had an increased number of pyramidal neurons, reduced astrocyte
reactivity based on morphology and GFAP staining, and extended the life span of these
mice in comparison to control PrP animals. This study shows both in vitro and in vivo that
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UPR activation via the PERK pathway alters the transcriptome and secreted molecules
of astrocytes and this is linked to a reduction in neuronal synapse formation. [93]. These
studies expand upon and corroborate the previous findings that PERK inhibition is
protective in prion infection [87, 89, 94, 95]. Further, this suggests that UPR-activated
astrocytes have pathogenic roles in prion infection and identifies PERK signaling as a
central driver in this process.
Consistent with the discovery that astrocytes have a significant role in directing the
milieu of the inflammatory environment in the CNS, viral infections have also shown to
induce the UPR in astrocytes, leading to pathogenic non-cell-autonomous astrocyte
dependent pathology. The HIV protein Tat has been shown to induce ER stress in
astrocytes leading to GFAP-dependent neurotoxicity [175]. Inflammation and expression
of the human endogenous retrovirus protein, syncytin-1, promote ER stress in astrocytes
in MS [176]. This study demonstrated that ER stress proteins were upregulated in MS
patient brains, along with the human endogenous retrovirus protein (HERV) syncytin-1.
Syncytin -1 induces splicing of XBP1 and leads to downstream inflammation. These
mechanisms were confirmed by transfecting primary human fetal astrocytes with
syncinctin-1. This induced splicing of XBP1, indicating that the IRE1 pathway is activated.
Further, Nos2 was concomitantly upregulated and contributed to oligodendrocyte toxicity
in the EAE model. Together, this suggests that IRE1 signaling is stimulated by the HERV
protein syncytin-1 to initiate a sXBP1-dependent nitric oxide and neuroinflammatory
response.
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Additionally, Zika virus has been shown to activate the UPR in astrocytes. ZIKV
infection of astrocytes caused an over expression of UPR-related genes BiP, XBP1,
CHOP, and growth arrest and DNA damage-inducible protein (GADD) 34, Under these

Figure 5.2 Proposed mechanisms by which endoplasmic reticulum stress
signaling in astrocytes impacts the overall CNS environment.
Here, we propose a model where astrocytes experience endoplasmic reticulum stress
during disease states, activating the Unfolded Protein Response. UPR-related
molecules are upregulated in astrocytes, concomitant with inflammatory genes. Further,
UPR-activated astrocytes have reduced capacity to support neuronal synapses and
activated UPR in astrocytes is associated with increased synaptic loss and lower
numbers of neurons during disease. Further, astrocytes have the capacity to “transmit”
ER stress to other neuronal cell types including other astrocytes, microglia, and
neurons. Figure was created in Biorender.
conditions, cell viability was decreased, RNA metabolism genes and micro-RNAs were
downregulated, however, astrocyte-derived soluble factors glial cell line-derived
neurotrophic factor (GDNF) and neuronal growth factor (NGF) were upregulated,
highlighting that some molecules were still being translated under ER stress conditions
[177]. However, these results are associated with UPR activation, and direct evidence for
the non-cell autonomous action of UPR signaling in astrocytes still requires investigation.
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These results lay the groundwork for further studies examining the role of ZIKV and other
neurotrophic viral infections in astrocytes.
In summary, astrocytes play a critical role at directing the overall CNS environment
due to their close physical and trophic connection to other CNS cells as well as blood
vessels. UPR activation is emerging as an important process by which astrocytes
influence the survival, activation and function of other CNS resident and infiltrating cells.

Discussion and Perspectives
The UPR has been studied in a multitude of disease states and cell types,
however, the astrocyte-specific roles of the UPR is a relatively new field. ER stress has
been primarily characterized in the CNS focusing on neurons and oligodendrocytes [155,
178]. As more studies are performed, it is evident that UPR activation has diverse roles
in each CNS cell type. A working model is proposed in Figure 5.2. For example, EAE is
ameliorated by PERK activation in oligodendrocytes, but PERK knockdown in astrocytes
had no effect on the development of EAE [137, 179]. Although the UPR is known to
activate pathways that have been associated with apoptosis, there is little evidence that
UPR signaling in astrocytes induces cell death. Instead, UPR-activated astrocytes are
posited to be in a unique position to contribute to the inflammatory environment of the
CNS because astrocytes are the most populous glial cell, can be neurotoxic, and direct
CNS inflammation by promoting microglial activation and leukocyte trafficking [7, 8, 180].
Inflammatory and reactive astrocytes are attributed to neurotoxicity in many disease
models. Understanding how astrocytes are fine-tuned to produce these neurotoxic
responses is of vital importance; neuronal loss cannot be overcome and leads to motor
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and cognitive decline. Here, we provide evidence that UPR signaling could substantially
contribute to astrocyte-driven neuronal dysfunction. To gain complete understanding of
the UPR in the CNS, more advanced cell-specific studies must be completed. Gain and
loss of function studies in vivo in astrocyte conditional models are underway and will
provide a wealth of information on the functional role of ER stress signaling in astrocytes.
Targeting UPR signaling in astrocytes has been tested in select models of
neurological diseases. For example, IRE1 knockdown in astrocytes is protective in the
EAE model of MS [137]. Therefore, IRE1 signaling may be pathogenic in neurological
diseases that are associated with excessive neuroinflammation. Astrocyte-specific
overexpression of GADD34, an eIF2α-specific phosphatase, is protective in prion disease
[93], consistent with studies using small molecules to target PERK signaling [95]. These
studies suggest a pathogenic role for PERK signaling in astrocytes in diseases driven by
protein misfolding. Together, with in vitro evidence that PERK signaling in astrocytes
promotes inflammation and that ER stress is transmissible [13, 93, 128, 154, 155, 157],
these studies suggest that UPR signaling in astrocytes may profoundly impact multiple
neurological diseases. Additional studies using astrocyte-selective Cre drivers such
GFAP-Cre [42, 181] and ALDH1L1-CreERT2 [182] to target specific UPR components in
additional disease models of neural injury and neurodegeneration will ultimately define
ER stress signaling in astrocytes and its impact on disease.
Further, recent studies have established that substantial regional heterogeneity of
astrocytes exists [46]. Currently, astrocyte specific UPR signaling has not been
characterized or compared across regional locations of the CNS. The location and
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composition of misfolded proteins is known to vary amongst each neurodegenerative
disease. Therefore, this prompts the possibility that UPR signaling in astrocytes can
greatly differ based on location, disease state or stage.
Critically, limited therapies and cures exist for most neurological diseases.
Therefore, it is logical to assume that identifying novel therapeutic targets to regulate
disease-associated signaling cascades is vital for the design of effective treatments.
Considering the well-established association of protein aggregation and accumulation in
neurological disorders and the recent advances in astrocyte biology, understanding how
astrocytes experiencing ER stress influence the CNS environment may be a critical link
in understanding signaling pathways that contribute to neurological dysfunction. ER
stress has been linked to neurotoxicity in models of neurodegeneration. However,
neurotoxicity may be the result of multiple unconfirmed mechanisms including: 1) initiation
of apoptosis by the UPR in neurons, 2) loss of supportive function in other CNS cells,
such as glia, 3) UPR signaling in glial cells have a gain of neurotoxic function, or 4) a
combination of these possibilities. Altogether, an accumulation of evidence suggests that
the duration, cell type, and inflammatory environment of the CNS dictates the
consequences of active UPR signaling.
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Table 0-1 Endoplasmic reticulum (ER) stress-induced changes in astrocytes
ER stress-induced changes in astrocytes
increased (↑),
decreased (↓),
no change (―)

Method

IL-1α/β

―

ELISA

IL-6

↑

ELISA, qPCR

IFN-γ

―

ELISA

[128]

TNF-α

―

ELISA

[128, 154]

MCSF

↑

ELISA

[128]

LIF

↑

ELISA*, qPCR

[13]

IL-11

↑/―

qPCR / ELISA

[13]

OSM

↑/―

qPCR / ELISA

[13, 154, 157]

CXCL1

↑

ELISA, qPCR

[128, 157]

CXCL9

―

ELISA

CXCL10

↑

ELISA, qPCR

CCL2

↑

ELISA

[128, 154, 157]

CCL3

↑

ELISA

[128]

CCL4

↑

ELISA

[128]

CCL5

―

ELISA

[128]

CCL11

↑

ELISA

[128]

CCL20

↑

qPCR

[128, 154]

Factor

Reference

Cytokines
[128]
[128, 154, 157]

Chemokines

[128]
[93, 128]

Growth factors / ECM proteins
VEGF

↑

ELISA

[128]

CNTF

↓

ELISA, qPCR

[13]

BDNF

―

RNAseq

[157]

GDNF

―

RNAseq

[157]

collagen

↓

LC/MS

[93]

fibronectin

↓

LC/MS

[93]

glypican-4

↓

LC/MS

[93]
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Complement
[157]

C1q

↓?

RNAseq

C3

↑

qPCR / RNA scope

Serping1

↓

qPCR

[93]

GFAP

―?

RNAseq

[157]

Vimentin

↑

qPCR

[93]

Nestin

―?

RNAseq

[157]

Lcn2

↑

qPCR

[93]

serpina3n

↓

qPCR

[93]

APOE4

↓

LC/MS

[93]

CD109

↓

qPCR

[93]

GADD45α

↑

qPCR

[157]

TRIB3

↑

qPCR

[154, 157]

ERO1B

↑

qPCR

[157]

[93]

Gliosis Markers

Stress Related
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